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ABSTRACT 
 
During muscle development, embryonic and fetal myoblasts in turn differentiate to 
form slow-twitch and fast-twitch fibers, respectively. While consistent data have been 
provided on the mechanisms involved in adult fiber remodeling, the molecular 
regulation of slow/fast specification during embryogenesis is still unclear. Previous 
work from our laboratory identified nuclear factor I X (Nfix) as a key regulator of 
fetal myogenesis. Nfix acts as an activator of several fetal-specific genes and at the 
same time as a repressor of embryonic genes (such as the slow myosin heavy chain 
isoform MyHC-I). The aim of my project was to better define the possible co-factors 
involved in Nfix function during muscle pre-natal development. Here we show that 
Sox6, a direct repressor of the slow-twitch phenotype, cooperates with Nfix in fetal 
muscle to silence MyHC-I expression at the transcriptional level. Sox6 and Nfix are 
co-expressed in fetal myoblasts and co-immunoprecipitate in muscle cells, suggesting 
contribute of both to a repressive complex acting during fetal myogenesis. By ChIP 
assay, we show that Nfix is required for the binding of Sox6 to the MyHC-I proximal 
promoter during muscle development. Moreover, we show that Sox6 is absolutely 
necessary for normal MyHC-I regulation. Importantly, Sox6 acts as an activator of 
MyHC-I rather than a repressor during embryonic myogenesis. Interestingly, we show 
that the zebrafish orthologs Nfixa and Sox6 cooperate in repressing the slow-twitch 
phenotype during zebrafish developmental myogenesis. These data demonstrate the 
evolutionary conserved cooperation of Sox6 and Nfix in the repression of embryonic 
muscle genes, pointing out to the importance of a synergy among transcriptional 
factors in the achievement of adult skeletal muscle phenotype. 
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STATE OF THE ART 
 
 
1. Skeletal muscle organization and function 
 
1.1 Characteristics of skeletal muscle 
Skeletal striated muscle is the most abundant tissue in the body and includes trunk 
and appendicular muscles, extra-ocular muscles, jaw and tongue muscles, laryngeal 
muscles and diaphragm. The fundamental functions of skeletal muscle are related to 
body mobility and posture maintenance, but it also plays an important role in whole 
body metabolic health. 
Skeletal muscle is composed of elongated, multinuclear cells that are called muscle 
fibers (or myofibers) and represent the contractile cells of the tissue. Myofibers of 
different muscles have variable diameter (from 10 to 100 µm) and length (from 1 mm 
to several cm). The myofiber plasma membrane (sarcolemma) entirely surrounds the 
cytoplasm (sarcoplasm). Most of the sarcoplasm is occupied by myofibrils, which 
represent the contractile machinery of the fiber. Each myofibril measures 1-2 µm in 
diameter and spans along the entire length of the fiber. The other cell organelles, such 
as myonuclei, mitochondria and the sarcoplasmic reticulum (SR) are located in a 
peripheral position around myofibrils. 
Muscle fibers run in parallel within the same muscle and are surrounded by a delicate 
net of connective tissue (endomysium) that contains blood capillaries, nerve endings 
and a basal membrane, which is in direct contact with the sarcolemma of each fiber 
(see Figure 1.1). The connective tissue also forms thicker layers that separate different 
fiber fascicles (perimysium), and an outer layer covering the muscle surface 
(epimysium). The connective layers have not just a role of containment, but are 
fundamental for the transmission of muscular force (Borg and Caulfield, 1980; 
Purslow and Trotter, 1992). At their extremities, muscle fibers are connected to the 
tendons by myotendinous junctions that enable a strong connection between the 
muscle fiber actin filaments and the tendon collagen fibrils (Huijing, 1999). The force 
generated by muscle is thus transferred via the tendons to bones (trunk, appendicular 
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and jaw muscles) or to connective tissue (mimic and extra-ocular muscles, 
diaphragm). 
 
 
 
 
1.2 Muscle contraction 
Myofibrils are composed of contractile units called sarcomeres which are connected 
in series and in parallel to form the typical striated pattern of skeletal muscle with 
alternating dark and light bands (see Figure 1.2). Sarcomeres are formed by several 
types of proteins: in particular, the interaction between thick myosin filaments and 
thin actin filaments is fundamental for muscle contraction. Each myosin molecule is 
composed of two heavy chains (MyHC) and four light chains (MyLC) arranged to 
form a long tail and a globular head. The myosin head is the motor domain of the 
myosin molecule, since it contains both the ATP- and the actin-binding domains that 
are required for hydrolyzing ATP and generating force. The tail of the molecule is 
formed by a long α-helix that allows dimerization of the heavy chain. In the thick 
Figure 1.1. Skeletal muscle structure. Skeletal muscle is organized in fiber 
fascicles that are surrounded by septa of connective tissue called perimysium. The 
connective tissue also forms the endomysium and the epimysium. Skeletal muscle 
fibers are directly connected to the tendon, which allows transmission of the force 
generated by muscle to the bone levers. Adapted from: Gray’s Anatomy of the 
Human Body, 2007. 
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filament, each myosin molecule is oriented with the head projecting towards the thin 
filaments. 
 
 
 
During contraction, the thick filaments pull the thin filaments towards the center of 
the sarcomere, thus shortening the length of the entire muscle fiber. At rest, regulatory 
proteins located on the thin filament prevent the interaction between myosin and 
actin: tropomyosin is a coiled-coil protein that covers the binding sites for myosin 
along the actin filament and is associated to a troponin protein complex. Each 
Figure 1.2. Sarcomere structure. a) Diagram showing the main components of the 
sarcomere. The A-band (anisotrope, dark) comprises thick myosin filaments that are 
linked at the center by the M-band assembly. The I-band (isotrope, light) comprises thin 
actin filaments that are tethered at the Z-disks and interdigitate with myosin filaments in 
the A-band. Nebulin and titin are giant proteins that contribute to the structure of the Z-
disk. b) Electron micrograph of a longitudinal section of fish white (fast) muscle 
showing the details of the sarcomere. Scale bar:  500 nm. Adapted from: Luther, 2009. 
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troponin molecule is formed by three different subunits: TnC, TnI and TnT. Troponin 
control of tropomyosin is regulated by sarcoplasmic calcium (Ca2+) concentration. 
During excitation-contraction coupling in skeletal muscle, Ca2+ ions are released into 
the sarcoplasm by the SR in response to depolarization of the sarcolemma. In 
presence of high Ca2+ concentrations, the TnC subunit of troponin binds to a total of 
four Ca2+ ions, thus allowing a conformational change of the tropomyosin molecule 
that uncovers the myosin binding sites on the actin filament and allows the sliding of 
the two filaments (Baylor & Hollingworth, 2011). The process of sarcomere 
contraction is dependent on ATP, which is hydrolyzed by the myosin head and 
releases the energy necessary for myosin head oscillation and filaments sliding 
(Huxley, 2004).  
Skeletal muscle contracts in response to a voluntary stimulus. Muscle fibers are 
stimulated to contract by the neurotransmitter acetylcholine (ACh) that is released at 
the ending of a somatic motor neuron in response to a train of action potentials 
(Fambrough 1979). Except during development, each muscle fiber is contacted by a 
single motor neuron: the ensemble of muscle fibers innervated by one neuron is called 
muscle unit, while that ensemble together with its motor neuron is called motor unit. 
The neuromuscular junction (NMJ) represents the communicative link between 
neuron and muscle fiber: here the pre-synaptic axon directly contacts the sarcolemma, 
which forms invaginations called post-synaptic folds where the nicotinic receptors for 
ACh are present. After the release of ACh by exocytosis from the pre-synaptic 
terminal, there is a change in the permeability of the muscle fiber membrane and 
increased entrance of positive ions that leads to membrane depolarization and 
generation of the action potential. The wave of depolarization extends to the 
transverse tubules, deep invaginations of the sarcolemma that contain voltage-sensing 
Ca2+ channels (dihydropyridine receptor, DHPR). DHPRs are functionally coupled to 
the Ca2+ release channels of the SR (ryanodine receptor, RyR) in molecular 
arrangements called tetrads. Activation of DHPR leads to a large and fast release of 
Ca2+ by the SR that triggers the contractile response of myofibrils. Calcium represents 
a powerful intracellular messenger in skeletal muscle fibers, being able not only to 
trigger contraction via binding to troponin, but also to activate protein 
phosphorylation or de-phosphorylation via activation of calmodulin and calcium-
dependent kinases (Wood & Slater, 2001). 
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1.3 Functional heterogeneity of skeletal muscle 
Adult skeletal muscle is composed of different populations of fibers, presenting a 
wide range of physiological and biochemical differences. This heterogeneity enables 
the same muscle to respond to different functional demands: from continuous or time-
prolonged actions (such as posture and locomotion) to fast and strong maximal 
contractions (such as swimming, sprinting, etc.). The first classification of muscles 
diversity was based on organoleptic properties such as color: slow-twitch muscles, 
characterized by oxidative metabolism, high myoglobin content and continuous 
activity, were generally defined as red muscle; in contrast fast-twitch muscles, 
characterized by glycolytic metabolism, low myoglobin content and phasic activity, 
were defined as white muscles (Needham, 1926). 
A further step in the characterization of muscle fiber types took place with the 
identification and the cloning of different MYH genes that specify for distinct MyHC 
isoforms in mammals (Peter et al. 1972; Schiaffino et al. 1988; Weiss et al. 1999) (see 
Figure 1.3). The central role of myosin in muscle contraction and the differential 
expression of several MyHC isoforms in various fibers make MyHC the best marker 
for fiber typing. It was thus possible to distinguish four different adult fiber types in 
mouse on the basis of the MyHC isoforms expression: slow-twitch type I fibers, 
expressing the slow MyHC isoform (MyHC-I or MyHC-β, encoded by MYH7), and 
three distinct fast-twitch type II fibers (IIa, IIx and IIb), each one expressing one of 
the fast adult MyHC isoforms: MyHC-IIa, MyHC-IIx and MyHC-IIb (encoded by 
MYH2, MYH1 and MYH4, respectively) (DeNardi et al. 1993; Chakkalakal et al. 
2012). Different biochemical approaches demonstrated the presence of a spectrum of 
fibers with pure and hybrid composition in MyHC isoforms, according to the 
following scheme: I ↔  I/IIA ↔  IIA ↔  IIA/IIX ↔  IIX ↔  IIX/IIB ↔  IIB (Gorza, 
1990; Bottinelli et al. 1994). The fiber types present differences in mechanical power 
(i.e., mechanical energy released per unit of time) and maximum velocity of 
shortening, which are intrinsically determined by the type of MyHC that is expressed 
in the fiber (Nyitrai et al. 2006). Both values increase in the following order: 
I<IIa<IIx<IIb, with IIb fibers exhibiting the highest values in all species and muscles 
examined up to now.  
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The different fiber types also exhibit distinct metabolic properties: type I fibers 
generate ATP by oxidative mitochondrial processes and have the ability to maintain 
contraction for long time without fatigue. Type II fibers have high content of 
glycolytic enzymes that generate ATP very rapidly but with limited duration of 
contraction (Nemeth et al. 1981; Park et al. 1987). However, type IIa fibers also 
possess the oxidative enzyme complement, and are therefore called fast oxidative 
glycolytic (FOG) fibers (Barnard et al. 1971).  
Significant variations in the fiber types exist among different species. For example, in 
rodent muscles type IIx fibers have intermediate levels of the oxidative enzyme 
succinate dehydrogenase (SDH) and intermediate shortening velocity between IIa and 
IIb fibers, while in human muscles, where MyHC-IIb expression is not detectable, IIx 
Figure 1.3. Heterogeneity of mammalian MyHC isoforms. Diagram showing the 
different mammalian MYH genes with the corresponding proteins and their expression 
pattern. On the left, a phylogenetic tree shows the relationships between the different 
MYH isoforms. §Expression limited to some mammalian species: in particular, the levels 
of MyHC-IIb vary between rodent and human muscles, the latter being virtually 
negative for MyHC-IIb. *MYH7b is expressed in both cardiac and skeletal muscle at the 
transcript level, but only in extra-ocular muscles at the protein level. Adapted from: 
Schiaffino & Reggiani, 2011. 
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fibers have the lowest content of SDH and the highest shortening velocity of all fiber 
types (Smerdu et al. 1994). Specific MyHC isoforms are also expressed in developing 
and regenerating muscle, and in specific anatomical districts, such as extra-ocular and 
jaw muscles (Wieczorek et al. 1985; Rossi et al. 2010). In particular, MyHC-emb and 
MyHC-neo (encoded by MYH3 and MYH8, respectively) are the most expressed 
during embryonic development, with a pattern that is recapitulated during muscle 
regeneration (Eusebi et al. 1986; Schiaffino et al. 1986; Whalen et al. 1990). 
During adult life, the fiber type is strictly regulated by extrinsic signals such as 
muscle activity and hormones. The program of fiber type specification during 
development and adulthood will be further discussed in Section 3. 
 
 
 
2. Skeletal muscle development and growth 
 
2.1 Mechanisms of myogenic differentiation 
During embryonic development, myofibers are formed by fusion of myogenic 
progenitors called myoblasts that arise from pre-somitic mesoderm (PSM) (Christ & 
Ordahl, 1995). By contrast, some of the head and neck muscles are derived from 
anterior paraxial unsegmented mesoderm and prechordal mesoderm (Buckingham et 
al. 2003). Proliferative myoblasts withdraw from the cell cycle at different 
developmental stages and give rise to differentiated post-mitotic myocytes, which in 
turn fuse with each other to form multinucleated muscle fibers. The process of 
differentiation into the skeletal myogenic lineage is tightly regulated at the molecular 
level. A family of basic helix-loop-helix (bHLH) transcription factors named muscle 
regulatory factors (MRFs) is able to activate the program of muscle differentiation by 
initiating the transcription of regulatory and structural muscle specific genes. The 
MRF family includes Myf5, MyoD, MRF4 and myogenin. Each of these transcription 
factors is able to myogenically convert non-muscle cells when ectopically expressed 
(Pinney et al. 1988; Choi et al. 1990; Liu et al. 2008). MRFs form heterodimers with 
other non-myogenic bHLH factors (typically the E proteins) and bind specific 
sequences of DNA called E-boxes (CANNTG) in the enhancers and promoters of 
muscle specific genes (Beylkin et al. 2006; Cao et al. 2010). In particular, Myf5 and 
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MyoD are activated during myoblasts proliferation and early differentiation (Emerson 
1990), which implies their involvement in maintenance of progenitor muscle cells, 
while MRF4 and myogenin are expressed in terminally differentiated muscle cells 
(Edmondson & Olson 1989; Wright et al. 1989). Expression of Myf5 and MyoD is a 
key step in the commitment into the skeletal muscle lineage, since disruption of both 
genes results in the complete absence of myogenic cells (Rudnicki et al. 1993), while 
single mutants display no major defects in myogenesis (Rudnicki et al. 1992). 
Myogenin mutant mice show dramatic reduction in all skeletal muscles, 
demonstrating that the other MRFs are not able to compensate for myogenin function 
(Hasty et al. 1993; Nabeshima et al. 1993). Moreover, myogenin is correctly 
expressed in MyoD:MRF4 double mutants but is not able to compensate for muscle 
formation, indicating that myogenin is not sufficient to induce muscle differentiation 
alone (Rawls et al. 1998). Interestingly, when the Myf5 gene is substituted with 
myogenin in the MyoD:Myf5 double mutant muscle differentiation takes place, even 
if with low efficiency, suggesting non-redundant functions for the different MRFs 
throughout development (Wang & Jaenisch, 1997). MRFs cooperate with different 
factors in order to activate the expression of muscle-specific genes. An important 
family of co-factors is the myocyte enhancer factor-2 (MEF2) family which bind to a 
specific sequence called MADS-box motif that is found in regulative regions of 
several muscle-specific genes (Olson et al. 1995). MEF2 factors can cooperate with 
heterodimers of myogenic bHLH proteins and E proteins, and the DNA-binding 
domains of these factors mediate the physical interaction required for functional 
cooperation (Molketin et al. 1995; Black & Olson 1998). Several recent studies have 
demonstrated that MyoD is required for enhancer activity in distal regulative regions 
of several muscle-specific genes, including myogenin, MyoD, Myf5 and MRF4 (Yee 
& Rigby, 1993; Cheng et al. 1993; Chang et al. 2004; Carvajal et al. 2008). Notably, 
MyoD is able to recruit the acetyltransferases p300 and PCAF leading to acetylation 
of histones H3 and H4 (Yuan et al. 1996; Puri et al. 1997; Rampalli et al. 2007). 
Further studies have suggested that epigenetic modification and chromatin 
arrangement might be important in limiting MRF recruitment to muscle enhancers 
(Cao et al. 2010; Blum et al. 2012), and putative co-factors of the MRFs (including 
NFATc, c-Jun, Runx1 and Meis) have been validated (Bengal et al. 1992; Knoepfler 
et al. 1999; Wang et al. 2005; Daou et al. 2013). The process of myogenic 
differentiation is tightly linked to cell cycle control: in fact, both Myf5 and MyoD 
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have been shown to be involved in myogenic progenitors expansion (Megeney et al. 
1996; Ustanina et al. 2007; Zhang et al. 2010), while myogenin is a marker of 
terminal differentiation involved in cell cycle exit (Andrès & Walsh, 1996). An 
extensive literature has supported a role for MyoD in cell cycle exit that is required 
for differentiation (reviewed in De Falco et al. 2006): in particular it was shown that 
MyoD null myoblasts are not able to withdraw from the cell cycle (Cornelison et al. 
2000). Moreover, MyoD has been shown to induce the expression of the Cdk inhibitor 
p21 that leads to activation of the retinoblastoma tumor suppressor protein (Rb) 
(Halevy et al. 1995; Zhang et al. 1999). However, it was recently reported that 
myogenin but not MyoD is sufficient to induce cell cycle exit in proliferating 
myoblasts by indirect regulation of different cell cycle genes (Liu et al. 2012). 
Moreover by ChIP analyses for MyoD and myogenin it was shown consistent overlap 
of MyoD and myogenin transcriptional targets (Blais et al. 2005). On the basis of 
these observations it was proposed that MyoD might create an open chromatin 
structure to recruit myogenin for strong transactivation of cell cycle inhibitor genes 
(Sing & Dilworth, 2013). 
Importantly, paired homeobox (Pax) genes are also involved in myogenic 
specification. Pax3 and its paralog Pax7 have fundamental and nonredundant 
functions in the specification of embryonic and post-natal myogenic progenitors. Both 
Pax3 and Pax7 are expressed in the dermomyotome, with the highest levels of Pax3 in 
the dorsal and ventral lips and the highest levels of Pax7 in the central domain 
(Kassar-Duchossoy et al. 2005). In particular, Pax3 is specifically required for proper 
migration of embryonic myogenic progenitors towards their target regions: in fact 
Pax3 directly induces expression of c-met, which encodes a tyrosine kinase receptor 
for HGF (hepatocyte growth factor/scatter factor) that is critical for myogenic cells 
delamination and migration (Epstein et al. 1996; Relaix et al. 2004). Moreover, Pax3 
and Myf5 control expression of MyoD which is not able to rescue the complete loss 
of muscle in Pax3:Myf5 double mutants (Tajbakhsh et al. 1997), whereas ectopic 
expression of Pax3 in embryonic tissues is sufficient to induce Myf5, MyoD and 
myogenin in both paraxial and lateral plate mesoderm (Maroto et al. 1997). Both Pax3 
and Pax7 expression are dependent on Six homeoproteins, which are considered to be 
at the apex of the genetic regulatory cascade that drives myogenic commitment (Rossi 
& Messina, 2014). At the limb bud level, Six1 and Six4 control migration and 
delamination of dermomyotomal cells through regulation of Pax3, whereas in the 
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myotome they positively regulate expression of myogenin, MRF4 and MyoD 
(Grifone et al. 2005). Notably, Pax3 is expressed at high levels in myogenic 
progenitors until E13.0 and it is then repressed, whereas Pax7 expression is 
maintained also in fetal myoblasts (Horst et al. 2006) and post-natal satellite cells (see 
Section 2.3). Pax3 acts upstream of MyoD during early myogenesis: indeed no MyoD 
transcript is detected in Splotch (Pax3 loss-of-function) mice. Moreover, MyoD is not 
able to rescue muscle loss in Pax3:Myf5:MRF4 triple mutants, since expression of 
MyoD is dependent on either Pax3 or Myf5 (Tajbakhsh et al. 1997). On the other 
hand, Pax7 is dispensable for embryonic muscle development (Seale et al. 2000), 
while in Pax3:Pax7 double mutants only the early myotome is formed and subsequent 
muscle development is interrupted (Relaix et al. 2005). As discussed in the next 
paragraph, a recent study has elegantly demonstrated a more defined role for Pax3+ 
and Pax7+ progenitors during development (Hutcheson et al. 2009). Importantly, 
Pax7 is able to directly activate Myf5 expression by recruiting the histone 
methyltransferase complex that directs methylation of histone 3 lysine 4 (H3K4) 
(McKinnel et al. 2008), thus inducing chromatin remodelling and transcriptional 
activation. Moreover, recent works have discovered genome-wide targets of Pax3 and 
Pax7 (Soleimani et al. 2012): it was shown in adult myoblasts that Pax3 binds only to 
a subset (5%) of Pax7 transcriptional targets. Despite the significant overlap in Pax3 
and Pax7 functions, Pax7 specifically regulates clusters of genes that are involved in 
proliferation and inhibition of differentiation by binding to the homeobox motif with 
higher affinity than Pax3. 
 	  
2.2 Pre-natal development  
All the skeletal muscles of the trunk and the limbs originate from the PSM. Somites 
are transient metameric structures that are formed by epithelial condensation of the 
PSM at either side of the neural tube (Nowicki & Burke, 2000; see Figure 1.4). The 
process of somite formation takes place from the anterior end of the PSM between 
embryonic day (E) 8.0 and E13.5 in the mouse (Pourquié, 2003). Immediately after 
epithelialization the ventral part of the somite undergoes an epithelial-to-
mesenchymal transition to produce sclerotome progenitors that will form rib and 
vertebral cartilage, while the dorsolateral domain forms the epithelial dermomyotome, 
that will give rise to dermis and skeletal muscle progenitors (Brill et al. 1995; Cossu 
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et al. 1996; Borycki et al. 1997). Cells from the dorsal medial lip of the 
dermomyotome migrate ventrolaterally to form epaxial dermis and myotome (which 
will contribute to back muscles), while cells from the ventral lateral lip contribute at 
the interlimb level to the hypaxial aspect of the myotome (Denetclaw et al. 1997; 
Olivera-Martinez et al. 2000). The myotome is formed by mononucleated myocytes 
that span alongside the entire somite and is eventually integrated into the trunk 
musculature (Tajbakhsh & Buckingham, 2000). Importantly, hypaxial progenitors 
migrate towards the lateral plate mesoderm to form limb and limb girdle muscles 
(Cinnamon et al. 1999). The process of delamination and migration of hypaxial 
progenitors into the limb bud is dependent on positional cues (in particular HGF) 
provided by mesenchymal non-myogenic cells of the limb bud (Birchmeier & 
Brohmann, 2000). Pax3+ cells migrating from the somite have not yet activated the 
myogenic program, and they start expressing Myf5 and MyoD only when they reach 
the limb (Tajbakhsh & Buckingham, 1994). 
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During the early phases of muscle development in the somite and the limb, 
commitment into the myogenic lineage is induced by paracrine factors secreted from 
the surrounding tissues. In particular, Wnt1 and Wnt3a (from the neural tube) and Shh 
(from the notochord) cooperate for the induction of Myf5 in the epiaxial 
dermomyotome domain, while Wnt7a (from the dorsal ectoderm) and FGF5 (from 
lateral mesoderm) induce expression of Pax3 and MyoD in the hypaxial domain 
(Munsterberg et al. 1995; Tajbakhsh et al. 1998; Borycki et al. 1999; Cossu & Borello 
1999). This is consistent with the phenotype observed in Myf5 and MyoD null 
embryos which display moderate defects in epaxial and hypaxial myogenesis, 
respectively (Rudnicki et al. 1992; Kablar et al. 1997). Among the different extrinsic 
signals that positively regulate myogenesis the most studied are Shh and Wnt: Shh is 
essential for dermomyotomal progenitors commitment into the myogenic lineage 
(Borycki et al. 1998), while abrogation of the Wnt pathway leads to dermomyotome 
defects and reduction of Pax3 and Myf5 expression (Borello et al. 2006). Moreover it 
Figure 1.4. Representation of somite development. After removal of surface 
ectoderm, the consecutive steps of somitogenesis are enlighted. Note that the anterior 
somites are the most differentiated ones, and consist of mesenchymal sclerotome, 
myotome and epithelial dermomyotome. On the contrary, posterior paraxial mesoderm 
is still unsegmented. Enlighted in the picture are also the distinct regions of the 
dermomyotome: epaxial (or dorso-medial), intercalated epaxial (or central) and hypaxial 
(or ventro-lateral) domains. Adapted from Arnold, 2006. 
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was shown that Bmp4 produced in the lateral plate mesoderm is important to inhibit 
muscle differentiation and to delay Myf5 and MyoD induction in Pax3+ cells 
(Pourquié et al. 1995). 
  
 
 
 
 
 
 
The process of skeletal muscle development occurs in subsequent steps that involve 
distinct populations of committed myoblasts (Biressi et al. 2007a, 2007b; Hutcheson 
et al. 2009) and result in the formation of different developing fibers (Cusella-De 
Angelis et al. 1994). ‘Embryonic’ myoblasts sustain a first wave of differentiation 
between embryonic day (E) 10 and E12 in the mouse and give rise to primary 
myofibers that establish the primitive shape of muscle and express high levels of 
MyHC-I and of the embryonic MyHC isoform (MyHC-emb) (Schiaffino et al. 1986; 
Stockdale et al. 1992). A second wave of muscle differentiation takes place between 
E15 and E18, driven by fetal myoblasts that form secondary fibers (initially smaller 
and surrounding primary fibers), which are characterized by low levels of MyHC-I 
and high levels of the fetal/neonatal isoform MyHC-neo (Eusebi et al. 1986; Lyons et 
al. 1990; Daou et al. 2013). Starting from E16.0, muscle fibers heterogeneity is 
Figure 1.5. Schematization of the different myogenic progenitors involved in 
muscle development. Embryonic myoblasts form slow primary fibers between E11 
and E13.5, while fetal myoblasts form fast secondary fibers between E14 and E18. 
The transcription factor Nfix is a marker of fetal myoblasts/myocytes. The Notch 
signal is gradually inactivated along the differentiation route. After E18, a third 
population of post-natal myoblasts called satellite cells is required for muscle growth 
and regeneration. From Rossi & Messina, 2014. 
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evident in skeletal muscle (Hagiwara et al. 2007). Eventually, primary fibers conserve 
the slow-twitch phenotype typical of embryonic muscle, while secondary fibers lose 
the expression of several embryonic-specific markers such as MyHC-I and acquire 
expression of fast-twitch markers such as muscle creatine kinase (MCK) and the 
glycolytic enzyme β-enolase (Eno3) (Ferrari et al. 1997; Biressi et al. 2007b). 
Embryonic and fetal myoblasts, once isolated from the embryo, are committed to a 
specific fiber type, suggesting the involvement of intrinsic factors rather than nerve 
activity in the establishment of fiber phenotype (Page et al. 1992). Moreover, 
embryonic and fetal myoblasts exhibit different requirements for several extrinsic and 
intrinsic factors, including TGF-β (Biressi et al. 2007b), MRF4 (Kassar-Duchossoy et 
al. 2005), Pax3/7 and β-catenin (Hutcheson et al. 2009). In a recent report (Hutcheson 
et al. 2009) genetic ablation of either Pax3+ or Pax7+ cells was conduced to 
demonstrate the specific roles of these myogenic populations in pre-natal 
development. Importantly, loss of the Pax3+ lineage leads to embryonic lethality and 
prevents the emergence of Pax7+ cells, whereas ablation of the Pax7+ lineage only 
leads to defects in fetal muscle development. These data suggest that the Pax3+ 
lineage is responsible for primary myogenesis. Interestingly, recent observations have 
demonstrated that a population of Pax7+ dermomyotomal stem cells is expanded 
during embryonic myogenesis by activation of the Notch pathway, and that this is 
critical for muscle progenitors maintenance (Mourikis et al. 2012), suggesting that a 
single self-renewing population may be responsible for the different myogenic waves.  
 
 
2.3 Post-natal muscle growth and regeneration 
Adult skeletal muscle is a stable tissue endowed with strong regenerative capabilities. 
After birth the number of myofibers in each muscle remains constant, but they grow 
in size by fusion of post-natal myoblasts, named satellite cells (SCs). SCs represent a 
third wave of myogenic progenitors, and in resting conditions (such as in adult 
uninjured muscle) they occupy a specific anatomical position underneath the basal 
membrane of skeletal fibers and outside the sarcolemma (Mauro, 1961). Beside their 
unique anatomical position, SCs can be identified by expression of several molecular 
markers, including Pax7 (Seale et al. 2000), Pax3 (that is expressed exclusively in 
diaphragm and forelimb muscle SCs) (Relaix et al. 2006), M-cadherin (Irintchev et al. 
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1994), c-Met (Allen et al. 1995), syndecan-3 and -4 (Cornelison et al. 2001), CD34 
(Beauchamp et al. 2000), α7-integrin (Burkin et al. 1999) and calcitonin receptor 
(Fukada et al. 2007). Among these, Pax7 is probably the most commonly used since it 
is specifically expressed in SCs during both the quiescient and proliferative state, and 
across different species such as mouse, human and zebrafish (Seale et al. 2000; 
McLoon et al. 2003; Hammond et al. 2007). SCs are present in all skeletal muscles 
but unequally distributed in different muscles and fiber types. In particular, a higher 
number of SCs is found associated with slow-twitch fibers compared with fast-twitch 
fibers of the same muscle (Gibson & Schultz, 1982). It was also reported that SCs are 
more frequently found adjacent to muscle capillaries (Schmalbruch & Hellhammer, 
1977) and to the NMJ (Wokke et al. 1989), suggesting that paracrine factors produced 
by non-muscle cells may have a role in the regulation of SCs activity. SCs number 
also decreases with age: while at birth SCs nuclei account for the 30% of sublaminar 
muscle nuclei, this percentage is reduced to <5% in 2 month old adult mice (Bischoff, 
1994). This decrease is mainly due to fusion of SCs with the growing fibers during 
the early post-natal period. In adult uninjured muscle SCs are mostly in G0 
(quiescence), but during the first phases of muscle regeneration they start proliferating 
and activate expression of Myf5 and MyoD (Cooper et al. 1999; Zammit et al. 2002). 
This amplified population of myoblasts (also called myogenic precursor cells, mpc) is 
responsible for repair of injured fibers and for the formation of a new pool of 
sublaminar SCs (Yao et al. 1993; Smith & Schofield, 1997; Heslop et al. 2001). 
Therefore SCs can be defined as a population of resident adult stem cells, 
characterized by their ability to differentiate into the myogenic lineage, and to self-
renew. However, the embryonic origin of SCs is still unclear. In recent years, many 
works have demonstrated that SCs arise from the Pax3/Pax7 myogenic progenitors of 
the dermomyotome, which remain undifferentiated into the late fetal period and are 
enveloped in the basal lamina of developing fibers (Gros et al. 2005; Relaix et al. 
2005; Sambasivan et al. 2013). Myogenic progenitors from the dorsal aorta can also 
contribute to post-natal muscle growth suggesting a common origin for SCs and 
endothelial progenitors (De Angelis et al. 1999). In the last years several works have 
demonstrated that different classes of non-myogenic cells such as hematopoietic stem 
cells, mesenchymal stem cells and muscle derived stem cells can contribute to 
regeneration upon transplantation or direct injection into injured skeletal muscle 
(reviewed in Tedesco et al. 2010). However, the role of these progenitors during 
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normal muscle development, and their possible contribution to the SCs pool has not 
yet been elucidated. Moreover, recent works have unambiguously demonstrated that 
ablation of the Pax7+ SCs pool leads to a complete loss of muscle regeneration 
(Lepper et al. 2011; Sambasivan et al. 2011). Pax7 has a critical role in SCs 
development since Pax7 null mice display normal pre-natal myogenesis but a drastic 
decrease in adult SCs number and reduced muscle regeneration (Seale et al. 2000; 
Oustanina et al. 2004). Further investigations have shown that in absence of Pax7 SCs 
undergo apoptosis instead of entering quiescence during the early post-natal period 
and Pax3 is not able to rescue for Pax7 in Pax3-expressing SCs (Relaix et al. 2006). 
Several works have investigated the heterogeneous nature of adult SCs: a first 
important discovery was achieved by using the Myf5-Cre and ROSA-EYFP Cre-
reporter alleles (Kuang et al. 2007). The authors have identified a subpopulation of 
SCs that have never expressed Myf5, and that divide by asymmetric cell division to 
give rise to a basal Pax7+/Myf5- stem cell and an apical Pax7+/Myf5+ progenitor cell 
committed to myogenic differentiation. Importantly, a recent report shows that 
ablation of Pax7 in Myf5+ cells leads to postnatal decline in SCs number and 
complete loss of muscle regeneration (Gunther et al. 2013). However, the Pax7+ SCs 
pool is not completely lost even in the absence of both Myf5 and MyoD, suggesting 
that a small amount of adult SCs might be derived by non-myogenic progenitors 
during normal muscle development. 
 
 
2.3 Muscle development in zebrafish (Danio rerio) 
Teleosts, and zebrafish in particular, have been widely used as animal models for 
practical reasons, including ease of genetic manipulation and transparence of 
embryos/larvae, which allows direct visualization of embryonic development. 
Myogenesis in teleosts shares several common features with mammals: the presence 
of different progenitor cells and fiber types, the formation of the embryonic 
dermomyotome and the presence of extrinsic signals regulating commitment and 
differentiation into the myogenic lineage. However, there are particular differences in 
several aspects of muscle development that will be briefly discussed here. 
In zebrafish, somitogenesis is immediately initiated after gastrulation. At the end of 
the first day post-fertilization (dpf), all the somites are formed and divided into 
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sclerotome and myotome domains (Kimmel et al. 1995). Moreover, a dermomyotome 
domain was also described in teleosts, in which Pax3 and Pax7 mark myogenic 
progenitors that are maintained during development, thus leading to a continuous 
contribution to larval and post-larval muscle growth (Stellabotte & Devoto, 2007). 
However, unlike in mammals, the first cells to commit into the myogenic lineage arise 
from the medial region of the PSM, which lies adjacent to the notochord. These 
mesodermal progenitors, called adaxial cells, start to express Myf5 and Myod before 
the formation of the dermomyotome, and eventually migrate from the notochord to 
form the mononuclear superficial slow-twitch fibers that uniquely express the slow 
MyHC isoform sMyHC1 and the transcription factor Prox1a (Devoto et al. 1996; 
Stickney et al. 2000). On the other hand, the dermomyotome progenitors will 
contribute to the medial multinucleated fast-twitch fibers of zebrafish muscle that 
specifically express the fast MyLC isoform MyLpfa (Liew et al. 2008). Importantly, 
the molecular mechanisms underlying slow and fast muscle lineage specification have 
been characterized in zebrafish. It was shown that secretion of Hedgehog (Hh) family 
members from the notochord and ventral spinal chord is required for the formation of 
slow-twitch muscle (Lewis et al. 1999; Barresi et al. 2000). Hh acts initially on 
adaxial cells and induces expression of the zinc finger domain transcription factor 
Prdm1a that functions as a direct repressor of several fast-twitch specific genes 
(including mylpfa, the fast troponin I tnni2 and the transcription factor sox6) (von 
Hofsten et al. 2008). This mechanism is not conserved in mouse development 
(Vincent et al. 2012). Moreover, it was shown that slow and fast muscle 
differentiation present different requirements for Myod and Myf5: slow adaxial cells 
differentiation requires either Myf5 or Myod and is disrupted in myf5:myod double 
morphants (Hammond et al. 2007). On the contrary, Myod is specifically required for 
fast-twitch fibers formation (Groves et al. 2005): it was recently shown that Pbx 
homeoproteins cooperate with Myod for the induction of the fast-twitch phenotype 
(Maves et al. 2007). 
After the embryonic period, new muscle fibers are formed in different locations by 
stratified hyperplasia in a way that is independent from myotome formation and Hh 
signaling (Barresi et al. 2001). This secondary zebrafish myogenesis is driven by 
Pax3+ Pax7+ cells of the dermomyotome and leads to the formation of both slow-
twitch and fast-twitch fibers (Stellabotte et al. 2007). 
 
 
21 
 	  	  
3. Molecular mechanisms of fiber type specification 
 
Here we will discuss in detail the molecular mechanisms involved in adult fiber type 
plasticity, and those involved in fiber type specification during the pre-natal period, 
including the Six homeoproteins, Nfix, Sox6 and MyoD/NFATc1. 	  
3.1 Adult fiber type plasticity 
It has been known for many years that cross innervation of slow-twitch and fast-
twitch muscles lead to a gradual transformation of the fiber characteristics toward the 
phenotype of the other fiber type (Pette and Vrbova, 1985). Moreover, direct 
electrical stimulation of the muscle gives rise to adaption of the fiber phenotype to the 
applied pattern of activity, suggesting that calcium intracellular levels and not trophic 
factor released by the motorneuron may be involved in fiber type plasticity (Windisch 
et al. 1998). Interestingly, the modulation of intracellular calcium is able to partly 
recapitulate the phenotype changes of fiber plasticity (Kubis et al. 1997). In the last 
years many molecular pathways have been identified which play important roles in 
adult fiber plasticity. The first to be discovered by in vitro and in vivo experiments 
was the calcineurin/NFAT pathway (Chin et al. 1998). Calcineurin is a cyclosporin-
sensitive, calcium-regulated serine/threonine phosphatase that controls the subcellular 
localization of the different NFATc factors in skeletal muscle cells and lymphocytes 
(Timmerman et al. 1996). In the presence of ectopic slow-twitch stimulation or 
constitutive expression of an activated form of calcineurin, NFATc proteins are 
shuttled into the fiber nuclei where they positively regulate expression of several 
slow-twitch markers, such as myoglobin, MyHC-I and the slow troponin C isoform 
(Chin et al. 1998; Naya et al. 2000; McCullagh et al. 2004; Calabria et al. 2009). 
Along with NFATc, the transcription factors MEF2 (MEF2A, B, C and D) are also 
involved in fiber type plasticity since both NFAT and MEF2 consensus binding sites 
have been identified within the regulative regions of slow fiber specific genes (Chin et 
al. 1998). MEF2 factors are maintained in an inactive state by members of the family 
of class II histone deacetylase (HDAC4, 5, 7), which form complexes with MEF2 
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proteins in the nucleus (Miska et al. 1999). The repression mediated by HDACs is 
controlled by the phosphorylation state of HDACs, which in turn is regulated by 
calmodulin dependent kinase (CaMK). In presence of high levels of intracellular 
calcium, CaMK is activated and phosphorylates HDACs, which are bound by 14-3-3 
proteins and exported in the cytoplasm (Lu et al. 2000; McKinsey et al. 2001), thus 
leading to MEF2 activation. In adult muscle, HDAC4, HDAC5 and HDAC7 are 
transcriptionally expressed at high levels in slow muscles; however, their protein 
levels are enriched in fast fibers since class II HDACs are selectively ubiquitinated 
and degraded via the proteasome in slow-twitch fibers (Potthoff et al. 2007). A cross-
talk exists between the calcineurin/NFAT and the MEF2 pathway: in fact, MEF2 
activity is strongly enhanced in the presence of activated calcineurin (Wu et al. 2000). 
Other factors have been shown to play a role in adult fiber plasticity: in particular 
AMPK (Winder et al. 2001), PPARs (Luquet et al. 2003) and PGC-1α (Lin et al. 
2005). 
 
 
3.2 Pre-natal fiber type specification: role of the Six 
homeoproteins 
The sine oculis homeobox (Six) proteins, a family of highly conserved transcription 
factors (Six1-Six6 in vertebrates) that play important roles in development, are 
characterized by the Six domain and the Six-type homeobox, both of which are 
essential for specific DNA-binding properties and interaction with the Eya/Dach co-
factors (Kawakami et al. 2000). Eya factors act as phosphatases that inhibit the 
activity of the co-repressor Dach; moreover Eya factors recruit components of the Six 
complex such as p300/CBP (Jemc and Rebay, 2007). Six1, Six4, Eya1 and Eya2 are 
all expressed in the dermomyotome and mark Pax3+ progenitors, even if their 
expression is maintained in differentiated muscle. It was reported that ectopic 
expression of Six1 and Eya2 in pre-somitic mesoderm is sufficient to induce 
expression of Pax3 and MRFs (Heanue et al. 1999). Analysis of Six1/Six4 and 
Eya1/Eya2 double mutant mice shows that expression of Pax3 is lost in the hypaxial 
dermomyotome, leading to aberrant delamination and migration of progenitor cells. 
Moreover, the expression of Myf5, MRF4 and MyoD is compromised with loss of all 
the muscles derived from the hypaxial dermomyotome, revealing a critical function 
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for the Six/Eya complex in myogenesis (Grifone et al. 2005; 2007). Recent reports 
demonstrated that Six proteins are recruited directly on the promoters of MyoD and 
Myf5 genes (Giordani et al. 2007; Relaix et al. 2013). Moreover, the myogenin 
proximal promoter is also controlled by Six/Eya through a conserved MEF3 binding 
site (Spitz et al. 1998), even if myogenin expression is partially retained in double 
mutant mice. Importantly, Six proteins also play a role in pre-natal fiber type 
specification: in fact it was shown that Six1/Six4 deficient dorsal muscles (that form 
normally) display down-regulated levels of fast-twitch markers and up-regulation of 
several slow-twitch markers, including MyHC-I at the protein level (Richard et al. 
2011). Moreover, absence of Six1/Six4 resulted in re-localization of the transcription 
factor Sox6 from the nucleus into the cytoplasm, suggesting a cross-talk between 
Six/Eya and Sox6 regulative networks (see Section 3.5). Six1 and Six4 are enriched in 
fast adult muscle fibers, and they are able to directly bind to the promoters of several 
fast-twitch genes in embryonic muscle (Niro et al. 2010).  
 
 
3.3 Pre-natal fiber type specification: role of Nfix 
Nuclear factor I x (Nfix) belongs to the Nfi family that in vertebrates comprises four 
genes: Nfix, Nfia, Nfib and Nfic (Gronostajski, 2000). They encode for site-specific 
DNA binding factors with a conserved N-terminal DNA-binding and dimerization 
domain and a C-terminal transactivation/repression domain. The homologs of these 
four Nfi genes have been identified in every vertebrate species examined from 
Xenopus laevis to mouse and human (Roulet et al. 1995; Chaudhry et al. 1997; 
Kulkami & Gronostajski, 1996). In contrast, the cephalocordate Amphioxus genome 
only contains one Nfi gene that has undergone several duplication events during 
chordate development (Fletcher et al. 1999). The Nfi transcripts are post-
transcriptionally modified by alternative splicing of exons in the 3’ regions (leading to 
different C-termini fused to the DNA-binding domain) and alternative promoter usage 
(Santoro et al. 1988; Inoue et al. 1990; Apt et al. 1994; das Neves et al. 1999). The 
alternative splicing is evolutionary conserved (Kruse & Sippel, 1994) and differently 
regulated in distinct cell types (Apt et al. 1994; Chaudhry et al. 1997). The Nfi factors 
bind as dimers to the palindromic consensus sequence TTGCC(N5)GCCAA with 
strong affinity (Nowock et al. 1985); however, Nfi factors can also bind to individual 
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half sites (Meisterernst et al. 1988). The Nfi factors were first identified as crucial 
regulators of adenovirus DNA replication (Nagata et al. 1983). Eventually, it was 
demonstrated that Nfi proteins play also fundamental roles in gene expression: Nfi 
consensus sequences are found in promoters and enhancers of tissue-specific genes 
that are important for development and differentiation of several organs, including 
brain (Bedford et al. 1998), kidney (Leahy et al. 1999), cartilage (Szabo et al. 1995), 
and skeletal muscle (Funk & Wright, 1992; Spitz et al. 1997). In particular, Nfix null 
mice show decreased growth rate from post-natal day (P) 8 to P22 and die at about 
P22 exhibiting brain malformation, defects in endochondrial ossification and in the 
gastrointestinal tract (Driller et al. 2007). However, when supplemented with soft 
dough feed, they increase their weight and can survive to adulthood (Campbell et al. 
2008).  By the use of these null strains, it has been shown that Nfix plays crucial roles 
in the development of cerebellar neurons (Piper et al. 2011). Moreover, Nfix is 
expressed in the adult subependymal zone and in the dentate gyrus of the 
hyppocampus, the two regions of adult brain that contain proliferative adult stem 
cells, and here drives direct repression of the Sox9 gene (Fuentealba et al. 2012; Heng 
et al. 2014). Importantly, high-throughput ChIP-seq with an antibody recognizing all 
the Nfi isoforms was performed in neural stem cells (NSCs) (Martynoga et al. 2013), 
revealing the ability of Nfi factors to bind to the enhancers of several neural-specific 
genes that are activated during quiescence (along with the transcriptional activator 
p300/CBP). Moreover, the authors have shown that Nfix is up-regulated when NSCs 
are treated with BMP4 (leading to an undifferentiated quiescent state), and that Nfix 
is both sufficient and necessary for the acquisition of quiescence in NSCs. 
The role of Nfi factors (and in particular Nfix) in skeletal muscle development has 
been addressed for the first time in a recent publication by our laboratory (Messina et 
al. 2010). In this extensive work it was demonstrated that Nfix is a master regulator of 
fetal-specific muscle transcription, acting both as a repressor of embryonic specific 
genes (in particular MyHC-I) and as an activator of fetal-specific genes (such as Eno3 
and MCK). The Nfix transcript and protein are barely expressed in embryonic 
myoblasts and muscle tissue and start to be expressed at high levels at the beginning 
of fetal myogenesis. Once activated in fetal myoblasts, Nfix binds to the promoter of 
the NFATc4 gene, thus leading to indirect MyHC-I silencing. Moreover, Nfix binds 
alone to the Eno3 proximal promoter thus activating Eno3 expression. Finally, Nfix is 
able to activate expression of MCK by forming a complex with PKCθ and MEF2A at 
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the 5’-upstream region of MCK. In particular, the presence of Nfix allows the binding 
between PKCθ and MEF2A and PKCθ-dependent phosphorylation of MEF2A, thus 
leading to binding of the complex at the MCK enhancer region (Ferrari et al. 1997). 
MEF2A is constitutively expressed in skeletal muscle, while PKCθ expression is 
activated in fetal myoblasts by Nfix and other unknown factors. As a consequence, 
conditional deletion of Nfix in fetal skeletal muscle results in higher levels of NFATc4 
and MyHC-I and lower levels of Eno3 and MCK, while ectopic expression of Nfix in 
embryonic muscle leads to activation of the fetal program and repression of 
embryonic/slow genes. The factors that are responsible for Nfix induction in fetal 
myoblasts are until now unknown: it was shown that Pax7 is sufficient to activate 
Nfix expression in embryonic muscle cells; however, Pax7 is not necessary for Nfix 
expression in fetal muscle, suggesting a more complicated mechanism. Intriguingly, a 
recent work has identified Nfix as a DNA-hypomethylated marker in human fetal 
tissue (compared to adult blood samples), suggesting an epigenetic regulation of the 
Nfix locus during pre-natal development (Wang et al. 2014). 
Importantly, our laboratory has also shown that the zebrafish ortholog nfixa has a 
conserved role in the repression of the embryonic muscle phenotype (Pistocchi et al. 
2013). Nfix has two ortholog genes in zebrafish: Nfixa and Nfixb, but only Nfixa is 
expressed in skeletal muscle. nfixa transcript has a peak at 2 dpf, in the transition 
period between the initial myotome formation and the stratified hyperplasia phase. As 
in mouse, Nfixa drives indirect repression of sMyHC1 via repression of nfatc4: 
indeed, knock-down of nfatc4 partly rescues the slower phenotype of nfixa 
morphants. Moreover, nfixa morphants display a strong motility phenotype (with 
partial or complete immotility) after 3 dpf: this is due to defects in the sarcoplasmic 
reticulum and loss of the RyR ion channel. This phenotype was never observed in 
Nfix null mice, suggesting that Nfix has both divergent and conserved functions in 
muscle development throughout vertebrate evolution. 
 
 
3.4 Pre-natal fiber type specification: role of Sox6 
The SRY-related HMG box (Sox) family comprises 20 genes that are divided in eight 
groups (SoxA-SoxH) in vertebrates (Schepers et al. 2002). The SoxD group has 
evolved from a single SoxD gene (Larroux et al. 2008): in fact invertebrates such as 
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C. Elegans possess only one SoxD gene, whereas a single copy of all the three SoxD 
genes (Sox5, Sox6, Sox13) is present in the lower vertebrate classes including 
gnathostoma (Bowels et al. 2000). Expression of the three SoxD factors has been 
demonstrated in several cell lineages, including chondrocytes (Lefebvre et al. 1998), 
oligodendrocytes (Stolt et al. 2006), erythroid cells (Dumitriu et al. 2006), vessels 
(Roose et al. 1998) and skeletal muscle (Hagiwara et al. 2000). Overlapping functions 
for Sox5 and Sox6 (which share high homology) have been reported during 
development of different tissues (Stolt et al. 2006; Lefebvre, 2010). The SoxD 
proteins differ from the rest of Sox factors for the presence of a N-terminal leucin 
zipper domain and a glutamine-rich domain that are important for protein-protein 
interactions (Connor et al. 1995; Iguchi et al. 2007). The family conserved HMG box 
domain that enables SoxD factors to bind a specific consensus sequence (AACAAT 
motif) is located in the C-terminal region (Lefebvre et al. 1998). The HMG box also 
allows interactions with other proteins (Yamashita et al. 2000), and contains the 
nuclear localization signals (NLS) that are required for nuclear-cytoplasmic shuttling 
of Sox factors (Malki et al. 2010). Importantly, SoxD factors lack trans-repression or 
trans-activation domains, but they are able to participate in transcriptional regulation 
(Lefebvre, 2010). For instance, Sox5 and Sox6 cooperate with Sox9 to activate 
extracellular matrix genes during chondrocytes development (Lefebvre et al. 1998; 
Han and Lefebvre, 2008). On the other hand, Sox5 and Sox6 are able to block Sox10-
dependent activation of myelin genes in oligodendrocytes (Stolt et al. 2006) by 
competing with Sox10 for the binding in the 5’-upstream regulative regions. 
Moreover, Sox6 has been shown to repress the cyclin D gene in pancreatic cells by 
forming a complex with HDAC1 and β-catenin (Iguchi et al. 2007) and to repress the 
Fgf-3 gene in association with the transcriptional repressor CtBP2 (Murakami et al. 
2001). Sox6 has important roles in the development of different organ and tissues. 
Therefore, the Sox6 null mice die at P7-P10 due to breathing failure (Smits et al. 
2001); moreover, they present severe dwarfism and abnormal sternum formation. The 
formation of cartilage is severely impaired in Sox5/Sox6 double mutants, suggesting 
functional redundancy for Sox5 and Sox6. 
In recent years, an important function for Sox6 in skeletal muscle has been identified 
(Hagiwara et al. 2005; 2007). In Sox6 null mice the activation of the fetal program is 
completely lost and by E16 several slow-twitch markers such as MyHC-I and slow 
TnI are dramatically up-regulated in fetal muscle. Sox6 is able to directly bind to the 
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proximal promoter of the MyHC-I gene at a consensus sequence that is located at -200 
bp from the TSS, in a regulative region that is critical for MyHC-I regulation in adult 
denervated soleus muscle (Huey et al. 2003). Importantly, ChIP-seq for Sox6 was 
recently performed on fetal differentiated myoblasts (An et al. 2011): the authors have 
identified 1066 binding sites that are particularly enriched in intronic and intergenic 
regions, in proximity to E-boxes and Tead/MCAT motifs, suggesting a direct function 
of Sox6 in the regulation of a wide range of genes. Strikingly, more than 90% of the 
total binding sites were overlapping with MyoD and myogenin ChIP-seq enriched 
regions. Most of the Sox6 targets were not associated with active Pol-II binding, 
suggesting that Sox6 acts prevalently as a transcriptional repressor in fetal muscle. 
Notably, the ChIP-seq has allowed identification of many Sox6 targets that are 
involved in skeletal and heart muscle function, including MyHC-I, MyHC-IIa, MyHC-
IIx, α-cardiac MyHC, Myh7b, Tnnc1, Tnni1, Prox1, Sox6, Nfatc3, and others. In 
particular, the authors have confirmed the binding of Sox6 to the MyHC-I proximal 
promoter region (-350 bp from the TSS) and also identified a second binding site in a 
distal muscle enhancer that is required for full gene activation in the adult soleus 
muscle and in the embryonic heart (Giger et al. 2000; Blow et al. 2010). Moreover, 
phenotypic characterization of a Myf5-Cre/Sox6flox/flox transgenic line has 
unambiguously demonstrated that Sox6 is required for fetal fiber specification: 
conditional deletion of Sox6 results in up-regulation of slow-twitch genes in all the 
developing fibers starting from the beginning of secondary myogenesis. Sox6 is 
expressed at the protein level in the nuclei of secondary MyHC-I negative fibers and 
occasionally in the cytoplasm of fetal and post-natal muscle fibers. It is known that 
Sox factors can be regulated by subcellular localization via interaction with the HMG 
box domain with nuclear transport proteins (Argentaro et al. 2003): all the SoxD 
proteins possess conserved NLS sequences and a nuclear export sequence (NES) (Sim 
et al. 2008). In particular, the N-terminal NLS binds to calmodulin and the binding 
allows nuclear translocation of Sox factors by an unknown mechanism (Hanover et al. 
2009). The C-terminal NLS binds to β-importin, leading to association with the 
RanBP2 nucleoporin and transport via the nuclear pore (Forwood et al. 2001). Finally, 
the NES is bound by the export receptor CRM1/exportin1 and nuclear export of Sox9 
and Sox10 in the developing gonad (Gasca et al. 2002). Moreover, Sox factors are 
targeted by different post-translational modifications, including phosphorylation 
(Huang et al. 2000), acetylation (Thevenet et al. 2004), sumoylation (Hattori et al. 
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2006). A recent work has also shown that Sox6 is post-translationally targeted by the 
E3 ubiquitin-ligase Trip12 for proteasome degradation (An et al. 2013), strongly 
suggesting that Sox6 may be regulated by sub-cellular localization/protein 
stabilization in skeletal muscle. 
The mechanisms involved in Sox6 activation during mouse development are until 
now unknown. It has been shown that Sox6 is not expressed in the developing 
dermomoyotome and myotome between E9.5 and E11.5 (Vincent et al. 2012), 
suggesting that Sox6 expression might be quickly activated at the beginning of 
embryonic or fetal myogenesis. Moreover, Six1/Six4 deficient epaxial muscles 
display relocalization of Sox6 from the nuclei to the cytoplasm and down-regulation 
of HDAC4, along with consistent up-regulation of embryonic-specific genes (Richard 
et al. 2011), suggesting that Six factors may be important in the regulation of Sox6 
expression. However, due to the severe phenotype of Six1/Six4 double mutants, it is 
unclear whether this is a direct transcriptional effect. Sox6 regulation is better defined 
in zebrafish muscle development: it is known that Hh-dependent Prdm1a expression 
directly represses Sox6 in adaxial cells and allows normal fast muscle fiber 
specification (von Hofsten et al. 2008). Sox6 is expressed in the fast domain of 
developing zebrafish from the 10-somite stage and represses several slow-specific 
genes such as smyhc1, tnnc1b and prox1a when ectopically expressed in adaxial cells. 
Reciprocally, knock-down of sox6 results in ectopic expression of Tnnc1b in fast 
muscle fibers at the protein level. Interestingly, morpholino (MO) mediated knock 
down of both myf5 and myod leads to sox6 down-regulation specifically in somites, 
suggesting that the MRFs may activate sox6 expression (Wang et al. 2011). In the 
same work it has also been shown that sox6 transcription is de-repressed in slow 
twitch muscle at 4 dpf, in the absence of Sox6 protein, suggesting a mechanism of 
post-transcriptional regulation in slow twitch fibers. Importantly, zebrafish sox6 
transcripts contain several recognition sequences for miR-499, a micro-RNA 
previously identified in mouse, that is located in the nineteenth intron of the Myh7b 
gene and negatively targets Sox6 mRNA (McCarthy et al. 2009; van Rooij et al. 
2009). Intriguingly, miR-499/miR-208 double null mice display decreased levels of 
MyHC-I, while forced expression of miR-499 under the MCK regulative regions leads 
to massive up-regulation of MyHC-I (van Rooij et al. 2009). In zebrafish, Hh-
dependent Prdm1a expression spatially restricts activation of Myh7b/miR-499 that is 
sufficient to repress Sox6 at the post-transcriptional level (Wang et al. 2011). 
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However, it is unlikely that this mechanism is conserved in mouse development, since 
Hh signaling and Prdm1 seem not to be involved in fiber type specification in 
mammals (Vincent et al. 2012). 
 
 
3.5 Pre-natal fiber type specification: role of MyoD/NFATc2 
As already mentioned in Section 3.1, the nuclear factors of activated T-cells (NFAT) 
play a pivotal role in adult fiber plasticity. Five NFAT genes have been identified: 
NFATc1-c4 (that are regulated by calcineurin) and NFAT5. The NFATc factors are 
all expressed in adult skeletal muscle and have different combinatorial effects on 
distinct MyHC isoform: in particular MyHC-I is actively regulated by all four 
isoforms, while MyHC-IIb is positively regulated only by NFATc4 (Calabria et al. 
2009). Intriguingly, NFATc3 cooperates with MyoD to induce myogenin expression 
during somite development (Armand et al. 2008). Most importantly, a recent work has 
demonstrated a critical role for NFATc2 and MyoD in the transcriptional activation of 
MyHC-neo during the fetal period (Daou et al. 2013). NFATc2/MyoD double null 
mice display loss of MyHC-neo in fetal and post-natal muscle with normal expression 
of MyHC-I and MyHC-emb. The MyoD/NFATc2 association is mediated by the C-
terminal domain and the DNA-binding domain of NFATc2 and by the HLH domain 
of MyoD. MyoD/NFATc2 bind directly to the MyHC-neo regulative regions, that 
contain several E-boxes and three NFAT binding sites. 
 
3.6 Post-natal fiber type specification 
During the early post-natal period the fiber type composition of each skeletal muscle 
undergo dramatic changes, due to maturation of the neuromuscular system, activation 
of thyroid hormone, and other unknown factors. For instance, between P0 and P22 in 
mouse the developmental MyHC isoforms MyHC-emb and MyHC-neo (that represent 
the majority of total MyHC at birth) are completely substituted by the adult isoforms 
MyHC-IIa, MyHC-IIx and MyHC-IIb in fast-twitch muscles (for example, the tibialis 
anterior, the gastrocnemius, the extensor digitorum longus [EDL], the vastus) 
(Schiaffino et al. 1988). The transcripts of MyHC-IIa, -IIx and -IIb are first detected 
by P2-5 in rat hindlimb muscles and display a specific spatial pattern of expression in 
different muscles: for example, in the tibialis anterior MyHC-IIa transcripts and 
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proteins are mostly expressed in deep regions, whereas MyHC-IIb transcripts are 
present only in the superficial areas (DeNardi et al. 1993).
Additionally, in fast-twitch muscle the small proportion of type I fibers that are 
present from the fetal period are selectively lost during early post-natal growth 
(Whalen et al. 1984; Agbulut et al. 2003). In contrast, in slow-twitch muscle (such as 
the soleus) the period of early post-natal growth is characterized by transformation of 
type IIa fibers into type I fibers (Kugelberg, 1976). These changes in fiber type 
composition can be explained by the combined action of intrinsic programs (i.e. 
activation of transcription factors, epigenetic regulation) and the effect of extrinsic 
signals (hormones, muscle activity, etc.). A role in post-natal muscle fiber switch has 
been proposed for different transcription factors, including Six1/Eya1 (Grifone et al. 
2004), PGC-1α (Handschin et al. 2007) and notably Sox6 (Quiat et al. 2011). 
Intriguingly, Sox6 is enriched in fast-twitch adult muscles, and conditional deletion of 
Sox6 under control of MCK-Cre leads to dramatic increase in MyHC-I, MyHC-IIa, 
MyHC-IIx and decrease of MyHC-IIb in fast-twitch muscles. However, by using a 
fetal/post-natal unspecific Cre, the authors are likely overestimating the effect of Sox6 
in post-natal fiber type specification. It is known that during this period the primitive 
polyneuronal innervation is lost and definitive motor units are formed (Jansen & 
Fladby, 1990), but the relationship with fiber type change has remained elusive. 
Denervation in the perinatal period significantly alters fiber type composition of slow-
twitch muscle, leading to complete loss of MyHC-I expression after 4 weeks 
(Gambke et al. 1983). On the contrary, the expression of MyHC-IIb in fast-twitch 
muscle is not altered with denervation (Butler-Browne et al. 1982) or by treating 
muscles with α–bungarotoxin (Weydert et al. 1987), suggesting an activity 
independent mechanism for type IIb fibers development, even if the down-regulation 
of MyHC-neo requires innervation (Russell et al. 1993). The thyroid hormone (that is 
produced at high levels during early post-natal development) has a positive effect on 
type IIb fiber type specification, since MyHC-IIb is precociously induced in neonatal 
muscles by thyroid hormone injection even in the absence of the nerve (Russell et al. 
1988). Importantly, SCs (that represent a third wave of myogenic progenitors active 
during the early post-natal period) may contribute to these changes by continuous 
incorporation into the growing myofibers during the early post-natal period. However, 
no formal evidence for SCs contribution to post-natal fiber type specification has been 
provided until now (Schiaffino & Reggiani, 2011). 
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AIM OF THE THESIS 	  
In recent years, several transcription factors involved in muscle fiber type 
specification have been identified, but the links among these factors have remained 
elusive. The aim of this work was to verify and characterize a possible cooperation 
between Nfix and Sox6 in the regulation of skeletal muscle development, focusing on 
fiber type specification. As reported in the State of the Art section, Nfix and Sox6 
share common targets in fetal muscle, and are both required for the achievement of 
normal muscle phenotype in rodents and teleosts. In this work we provide evidences 
for functional cooperation between Nfix and Sox6 that is necessary for normal muscle 
development. We also demonstrated that this cooperation is evolutionary conserved 
between mouse (Mus musculus) and zebrafish (Danio rerio).  
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MAIN RESULTS 	  
 
Pericytes resident in postnatal skeletal muscle differentiate into muscle fibers and 
generate satellite cells 
As reported in the State of the Art section, the contribution of non-myogenic 
progenitors to muscle fiber growth and SC pool during development has never been 
demonstrated. Importantly, we have shown that during the early post-natal period in 
mouse, perivascular cells (pericytes) positive for TN-AP (tissue non-specific alkaline 
phosphatase), NG2, PDGFRβ and negative for the endothelial marker VE-Cadherin 
actively contribute to muscle fibers growth by hyperplasia, and also produce new 
satellite cells that form a reservoir subsequently activated during muscle regeneration 
(Dellavalle et al. 2011). Clonally-cultured pericytes are bipotent cells that 
differentiate into both vascular smooth muscle cells and skeletal muscle cells. These 
results are not in contrast with the recent finding that ablation of Pax7 positive cells 
leads to a complete loss of muscle regeneration (Lepper et al. 2011) since we 
demonstrated that TN-AP positive cells acquire expression of Pax7 before 
differentiating into the skeletal muscle lineage. To our knowledge, this is the first 
report proving the contribution of non-myogenic progenitors (here identified as 
pericytes) to skeletal muscle homeostasis and regeneration. 
 
 
The transcription factors Nfix and Sox6 cooperate in regulating muscle 
fiber type specification during pre-natal development 
 
Sox6 is expressed in both embryonic and fetal muscle and plays different roles in 
fiber type specification 
Previous analyses conduced in other laboratories (Hagiwara et al. 2007; An et al. 
2011) have unambiguously demonstrated that Sox6 is able to directly bind to the 
regulative regions of different embryonic-specific markers in fetal muscle cells, thus 
repressing them. However, a detailed characterization of Sox6 expression in the 
developing muscle has been never addressed. We demonstrated that Sox6, at variance 
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with Nfix, is expressed in both embryonic (E12.5) and fetal (E16.5) purified 
myoblasts. By the use of a polyclonal anti-Sox6 antibody we found that Sox6 protein 
is expressed in skeletal muscle cells starting from E12.5 and at this stage it is mainly 
detected in the cytoplasm of myogenin/MyHC positive myocytes. Then, starting from 
E16.5 many of the newly formed skeletal fibers acquire nuclear staining for Sox6, and 
by E17.5 its expression is completely restricted to secondary fibers that are negative 
for MyHC-I. By Western Blot on fractionated muscle lysates, we were able to 
demonstrate that Sox6 protein is present in both nuclear and cytoplasmic fraction of 
embryonic muscle but only in the nuclear fraction of fetal muscle, suggesting that 
Sox6 is regulated via sub-cellular localization during pre-natal myogenesis. In order 
to better elucidate Sox6 functions during muscle development, we analyzed 
embryonic and fetal skeletal muscle samples from the Sox6 null mouse strain (Smits 
et al. 2001) with different biochemical approaches. Unexpectedly, we found that Sox6 
has opposite functions in fiber type specification between primary and secondary 
myogenesis. In particular, Sox6 acts as an activator of MyHC-I in embryonic muscle, 
whereas in fetal muscle it is critical for MyHC-I transcriptional repression. As a 
result, Sox6 null embryos display reduced levels of MyHC-I, while Sox6 null fetuses 
show dramatic up-regulation of MyHC-I, which leads to complete disruption of fetal 
fiber specification. Therefore, we focused on Sox6 function during the embryonic 
period (E12.5), which was not previously described. By ChIP assay, we identified two 
direct targets of Sox6 in embryonic muscle: MyHC-I and Eno3, which are regulated in 
opposite ways. Interestingly, Eno3 is markedly up-regulated in Sox6 deficient 
embryonic muscle, which is suggestive of a slow-to-fast conversion that is also 
observed when Nfix is ectopically expressed during embryonic myogenesis under the 
control of a muscle-specific enhancer (Messina et al. 2010). 
 
Nfix and Sox6 non-redundantly and cooperatively regulate fetal fiber 
specification 
In order to demonstrate a possible functional cooperation between Nfix and Sox6, we 
analyzed fetal skeletal muscle from the Nfix null strain (Campbell et al. 2008) that 
displays up-regulation of MyHC-I as previously reported (Messina et al. 2010). 
Notably, we found that Sox6 protein is invariantly expressed in the nuclei of 60% of 
total muscle fibers, confirming that nuclear/cytoplasmic shuttling of Sox6 in the fetal 
period is not regulated by Nfix. However, we found a strong increase in the 
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percentage of Sox6/MyHC-I double positive fibers in Nfix null muscle, suggesting 
that Nfix is required for Sox6-dependent repression of MyHC-I. To elucidate a 
mechanism of cooperation, we performed co-immunoprecipitation (Co-IP) assay in 
differentiated C2C12 myoblasts: the results show that Sox6 and Nfix can physically 
associate with each other, suggesting the formation of a transcriptional complex. To 
demonstrate the recruitment of the Nfix/Sox6 complex at the MyHC-I promoter, we 
performed chromatin immunoprecipitation (ChIP) for Sox6 in wild type and Nfix null 
fetal myotubes. We found that the binding between Sox6 and the proximal MyHC-I 
promoter is completely abolished in the absence of Nfix. However, Sox6 is still able 
to bind to a distal muscle-specific enhancer of MyHC-I. Both these regions have been 
previously identified as functional Sox6-binding sites in fetal myotubes, but only the 
proximal region is required for the repressive activity of Sox6 (An et al. 2011). 
Moreover, in absence of Nfix, Sox6 is aberrantly present at the Eno3 promoter and 
here it is likely repressing Eno3 expression. These data demonstrate that Nfix is 
required for the binding ability and function of Sox6 in fetal muscle. 
In a parallel way, we sought to investigate whether Sox6 is required for normal Nfix 
function during fetal myogenesis. Hence, we performed different analyses on wild 
type and Sox6 null fetal muscle and found that Nfix is normally expressed in the 
absence of Sox6. In both fetal muscle and cultured fetal myotubes we found a slight 
decrease in Nfix mRNA levels, but no differences in Nfix protein expression. 
Importantly, NFATc4 – a known negative target of Nfix (Messina et al. 2010) – is 
correctly down-regulated in Sox6 null fetal muscle, suggesting that Nfix is still able to 
regulate some of its target genes in the absence of Sox6. However, NFATc4 down-
regulation has no effect on MyHC-I expression that is drastically up-regulated in Sox6 
null fetal muscle. Moreover, Eno3 expression is lost in the absence of Sox6, 
suggesting that Nfix and Sox6 cooperate for activation of Eno3. Taken together, these 
data demonstrate that functional cooperation between Nfix and Sox6 is necessary for 
normal fetal fiber specification in skeletal muscle. 
 
Functional cooperation of Sox6 and Nfixa is evolutionary conserved in zebrafish 
It is known that both the zebrafish Sox6 and Nfixa have an evolutionary conserved 
role in the repression of slow-twitch genes in zebrafish (von Hofsten et al. 2008; 
Pistocchi et al. 2013). We thus wondered whether this functional cooperation between 
Nfixa and Sox6 is also conserved in zebrafish myogenesis. As a preliminary analysis, 
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we performed immunofluorescence for Sox6 on 48 hours post-fertilization (hpf) 
embryos: we found that Sox6 is expressed in the majority of muscle fiber nuclei. 
Intriguingly, we found that the outer superficial fibers positive for sMyHC1 present 
cytoplasmic staining for Sox6, suggesting that Sox6 subcellular localization may be 
differentially regulated in slow and fast muscle domains during zebrafish 
development. In order to elucidate the role of Sox6 in slow-twitch genes regulation, 
we performed morpholino (MO) mediated knockdown of sox6 (von Hofsten et al. 
2008). By qRT-PCR analysis we found that the expression of slow-twitch specific 
genes such as smyhc1 and prox1a is markedly increased in absence of Sox6, whereas 
fast-twitch genes such as mylpfa (fast myosin light chain isoform) and tnnc2 (fast 
troponin C isoform) are expressed at equal or lower levels. Moreover, the nfixa 
transcript is drastically up-regulated since 24 hpf in sox6 morphants, suggesting that 
Sox6 might negatively regulate nfixa, whereas nfatc4 is prematurely down-regulated, 
likely reflecting high Nfixa levels. We conclude that Sox6 is a critical repressor of the 
slow-twitch phenotype in zebrafish, and that Nfixa is not able to compensate for sox6 
knockdown. To verify a possible cooperation between Nfixa and Sox6, we performed 
co-injections of suboptimal doses of sox6-MO and nfixa-MO. Strikingly, qRT-PCR 
results show that smyhc1 and prox1a are significantly up-regulated in the double 
morphants, whereas mylpfa levels do not change. Moreover, our analysis reveals that 
sox6 and nfixa transcripts are up-regulated in nfixa and sox6 morphants respectively, 
suggesting a mechanism of compensation that is lost when both factors are targeted 
for knockdown. Therefore, we conclude that functional cooperation of Sox6 and Nfix 
is evolutionary conserved in mouse and zebrafish.  
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DISCUSSION AND 
PERSPECTIVES 
 
In the recent years, many works have demonstrated that the intrinsic transcriptional 
properties of embryonic and fetal muscle progenitors are important to set the fiber 
type in the absence of nerve activity. Moreover, several transcription factors 
contributing to whole muscle fiber type specification have been identified, including 
Sox6 (Hagiwara et al. 2007; An et al. 2011), Nfix (Messina et al. 2010), Six1/Six4 
(Richard et al. 2011) and the NFAT factors (Daou et al. 2013). However, the network 
of transcription factors controlling fiber type specification during embryogenesis is 
still far from being fully characterized, and functional interactions among the different 
regulators are until now completely unknown. In this work we provided evidence for 
functional cooperation of Nfix and Sox6 in the repression of the slow-twitch 
phenotype during fetal muscle development. At variance with Nfix, which is a 
specific marker of fetal myogenesis (Messina et al. 2010; Mourikis et al. 2012), Sox6 
is expressed in both embryonic and fetal purified myoblasts at the mRNA and at the 
protein level. Consistently we found that Sox6 protein is expressed at high levels in 
skeletal muscle in vivo starting from E12.5. This was unexpected, since Sox6 is 
known to be a repressor of MyHC-I, which along with MyHC-emb is expressed in all 
embryonic fibers (Hagiwara et al. 2007; Hutcheson et al. 2009). It is known that the 
Sox6 transcript is absent in mouse embryonic myotome from E9.5 to E10.75 (Vincent 
et al. 2012), suggesting that Sox6 might be quickly activated in embryonic myoblasts 
at the beginning of primary myogenesis. However, we found that Sox6 protein is 
differentially localized in embryonic and fetal muscle and during the embryonic 
period is mainly found in the cytoplasm of myocytes and myogenic cells. It is known 
that Sox factors are regulated by subcellular localization in different tissues (Malki et 
al. 2010). Sox6 is aberrantly accumulated in the cytoplasm of fetal fibers lacking both 
Six1 and Six4, thus leading to an up-regulation of slow-twitch genes (including 
MyHC-I) and a consequential decrease in fast-twitch genes expression (Richard et al. 
2012). Moreover, Sox6 protein was found in the cytoplasm of muscle fibers in post-
natal and adult mouse (An et al. 2011), suggesting that an unknown mechanism 
controlling Sox6 subcellular localization might be important in regulating Sox6 
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function in fiber type specification. The recent finding that Sox6 is targeted for 
proteasomal degradation by the E3 ubiquitin ligase Trip12 in C2C12 myoblasts (An et 
al. 2013), strongly suggests that Sox6 function may be specifically controlled at the 
post-translational level. However, Sox6 protein was also found in the nuclei of 
embryonic myocytes, suggesting that Sox6 may be active as a transcription factor 
during primary myogenesis. Consistently, we found two downstream targets of Sox6 
in embryonic muscle: MyHC-I and Eno3, which are regulated in opposite ways. To 
our knowledge, this is the first report of a possible function for Sox6 in the 
transcriptional regulation of embryonic muscle. Unexpectedly, Sox6 deficiency 
during primary myogenesis leads to a faster muscle phenotype with low levels of 
MyHC-I and high levels of Eno3. This is followed in Sox6 null fetuses by dramatic 
up-regulation of MyHC-I and loss of Eno3 expression. These data are consistent with 
previous characterizations of the Sox6 null phenotype (Hagiwara et al. 2007; An et al. 
2011; Quiat et al. 2011) and demonstrate that Sox6 plays opposite roles in fiber type 
specification during development. It was shown by ChIP and ChIP-seq analyses that 
the MyHC-I regulative regions contain at least two conserved binding sites for Sox6 
(promoter and enhancer), while no Sox6 binding sites were found in the Eno3 
promoter (An et al. 2011). We found that Sox6 binds to both MyHC-I binding sites in 
embryonic and fetal myogenic cells but with different affinity (higher in fetal 
myotubes). Moreover, Sox6 binds to the Eno3 promoter in embryonic but not in fetal 
myoblasts. Thus, the binding ability of Sox6 is differentially regulated in discrete 
myogenic progenitor populations or at different times during development, which 
contributes to the high versatility of Sox6 functions. In contrast, we have shown that 
Nfix acts as a repressor of the slow-twitch phenotype in both embryonic and fetal 
muscle. 
It is known that SoxD factors, lacking trans-acting functional domains, have a critical 
requirement for co-factors in order to regulate transcription of target genes (Murakami 
et al. 2001). Therefore, it is likely that the reversal in Sox6 function is due to different 
factors that are progressively recruited and activated during muscle development. 
Preferential partners of Sox6 during embryonic myogenesis are likely positive 
transcriptional regulators, such as the MRFs (MyoD and Myog in particular), which 
bind to the same regulative regions of Sox6 in muscle cells (An et al. 2011). Then, 
starting from E16.5, we found that Nfix acts as a fundamental co-factor of Sox6, able 
to physically associate with Sox6 and to facilitate its binding with the MyHC-I 
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regulative regions, in particular the proximal promoter that was shown to be critical 
for Sox6-dependent fetal repression (Hagiwara et al. 2007). Strikingly, our ChIP 
analysis reveals that in absence of Nfix the binding status of Sox6 in fetal myotubes 
resembles that of embryonic differentiated myoblasts, in particular for Eno3. 
Moreover, our study on Nfix null and Sox6 null fetuses clearly demonstrates that Sox6 
and Nfix are independently expressed during secondary myogenesis and that neither 
Sox6 nor Nfix are able to restore wt MyHC-I expression when the other one is not 
present. Finally, we demonstrated that Sox6 is required for at least two of the Nfix 
transcriptional functions in fetal muscle: repression of MyHC-I and activation of 
Eno3. The transcriptional regulation of NFATc4 and MyHC-neo was not affected, 
suggesting that Sox6 is dispensable for the Nfix-induced repression of NFATc4 and 
for MyoD/NFATc2-induced activation of MyHC-neo (Daou et al. 2013). 
In this work we have also provided evidence for a conserved transcriptional 
cooperation of Sox6 and Nfixa in zebrafish. Sox6 is expressed both at mRNA and 
protein levels in fast muscle fibers that are negative for sMyHC1, and it is here co-
expressed with Nfixa that is required for sMyHC1 down-regulation after 72 hpf 
(Pistocchi et al. 2013). We show that, as in mouse, Sox6 is crucial for repression of 
slow-twitch genes, even in presence of elevated Nfixa levels. Moreover, our double 
MO assay clearly reveals that the two factors can cooperate in repressing the slow 
muscle phenotype, whereas expression of fast-twitch genes such as mylpfa (Liew et 
al. 2008) was unaffected. 
In conclusion we have presented a complex model of regulation of the 
embryonic/fetal transcriptional switch that not only involves Nfix activation, driven 
by Pax7 and other unknown factors (Messina et al. 2010), but also functional 
cooperation between Nfix and Sox6 that is conserved in mammals and teleosts. Future 
work will be addressed to study the relationship between Sox6 and Nfix in the context 
of post-natal development and adult skeletal muscle growth. 
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Skeletal muscle fibres form by fusion of mesoderm progenitors called myoblasts. After birth, 
muscle fibres do not increase in number but continue to grow in size because of fusion of satellite 
cells, the postnatal myogenic cells, responsible for muscle growth and regeneration. Numerous 
studies suggest that, on transplantation, non-myogenic cells also may contribute to muscle 
regeneration. However, there is currently no evidence that such a contribution represents a 
natural developmental option of these non-myogenic cells, rather than a consequence of 
experimental manipulation resulting in cell fusion. Here we show that pericytes, transgenically 
labelled with an inducible Alkaline Phosphatase CreERT2, but not endothelial cells, fuse with 
developing myofibres and enter the satellite cell compartment during unperturbed postnatal 
development. This contribution increases significantly during acute injury or in chronically 
regenerating dystrophic muscle. These data show that pericytes, resident in small vessels of 
skeletal muscle, contribute to its growth and regeneration during postnatal life. 
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Pericytes resident in postnatal skeletal muscle 
differentiate into muscle fibres and generate 
satellite cells
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Satellite cells are myogenic stem/progenitor cells of postnatal skeletal muscle and have a prominent role in tissue growth and regeneration. Recent work has demonstrated that, like 
embryonic myoblasts, most, if not all, satellite cells in the body 
originate from the Pax3 + /Pax7 +  cells in the somites and become 
detectable in their speci!c niche, underneath the basement mem-
brane of skeletal muscle !bres, from approximately E16.5 in the 
mouse1–4. However, numerous reports indicate that, on transplan-
tation, cells from tissues other than muscle (for example, bone 
marrow, brain, adipose tissue and blood vessels) can fuse with 
regenerating muscle !bres and also contribute to the satellite cell 
pool5–8. It is therefore important to understand whether contribu-
tion to skeletal muscle by non-myogenic progenitors is restricted 
to arti!cial conditions created by transplantation, or whether it 
occurs during unperturbed pre- and post-natal development. To 
address this question, we used a Cre-loxP lineage tracing strat-
egy to follow the in vivo fate of progenitors associated with the 
vasculature. Recently, we reported that pericytes associated with 
the micro-vasculature of human muscle are able to di"erentiate 
into skeletal muscle in vitro and in vivo, on transplantation into 
dystrophic, immune-de!cient mice9. A major problem in peri-
cyte biology is the lack of speci!c markers10. #us, we chose alka-
line phosphatase (AP) that, in contrast to other pericyte markers 
such as the neuro-glial 2 proteoglycan (NG2)11 or platelet-derived 
growth factor receptor beta (PDGFR?)12, is not expressed in skel-
etal muscle !bres, nor in myogenic progenitors, but is restricted 
to the micro-vasculature of striated muscle in postnatal life. #is 
strategy allowed us to label a subset of pericytes and endothelial 
cells, as in the mouse both of these cell types express AP. A second 
reporter mouse Tg:VE-Cadherin(PAC)-CreERT2 (ref. 13) allowed 
us to selectively follow endothelial cell fate inside skeletal muscle. 
Our data show that during postnatal growth, pericytes, but not 
endothelial cells, contribute to !bre development and to the sat-
ellite cell pool and, that this contribution is further enhanced by 
acute or chronic tissue regeneration.
Results
Alkaline phosphatase is expressed in muscle microvessels. In 
preliminary studies, we examined in great detail the expression 
of AP in postnatal and adult skeletal muscle. AP expression is 
robust and widespread in tissues such as intestine, bone and 
liver, whereas it is restricted to the micro-vasculature of other 
tissues, such as striated muscles, in many species14–16 including 
human9. We performed extensive immuno$uorescence, confocal 
analysis on adult and juvenile skeletal muscle to con!rm AP 
expression in vessel-associated cells. Both AP +  endothelial cells 
and pericytes were unequivocally identi!ed by their anatomical 
niche and by labelling with di"erent antibodies that recognize 
either one or the other cell population (Fig. 1a–l; Supplementary 
Fig. S1a–c).
We never detected AP +  cells that are not associated with small 
vessels; on the other hand, less than 20% of total vessels express AP. 
#e in vivo expression pattern of AP in postnatal skeletal muscle 
was also con!rmed by analysing mice carrying one copy of the 
TN-AP?geo allele17. In this mouse strain, ?-gal +  cells are only asso-
ciated with vessels, whereas myo!bres and satellite cells are always 
unlabelled (Supplementary Fig. S1d).
In skeletal muscle, pericytes and satellite cells are o%en adjacent 
to each other18 (arrows in the Fig. 1m); however, AP was never 
detected in Pax7 +  or MyoD +  satellite cells at any time exam-
ined; an example at P7 is shown in Supplementary Figure S1e,f, 
respectively. #ese results were con!rmed by enzymatic staining 
for AP on muscles sections from the Myf5nlacZ/ +  mouse (express-
ing nuclear ?-gal only in Myf5 +  cells19) (Fig. 1n), even a%er 
cardiotoxin-induced regeneration (Supplementary Fig. S1g–j). 
Notably, AP activity was invariably detected outside the basement 
membrane encircling skeletal muscle !bres and co-localized with 
platelet endothelial cell adhesion molecule (Pecam)-positive ves-
sels (Fig. 1o). Moreover, in single myo!bres isolated from EDL or 
Tibialis anterior (TA) of P30 Myf5nlacZ/ +  mice, satellite cells were 
found not to express AP during activation, proliferation or dif-
ferentiation (Supplementary Fig. S1k–m). In contrast, nonpuri-
!ed primary cultures of skeletal muscle contained both AP +  and 
Myf5 +  cells, but double positive cells were never detected (Supple-
mentary Fig. S1n). Satellite cells-derived clones did not express AP 
during proliferation (5 days in vitro) or a%er di"erentiation (10 
days in vitro) (Supplementary Fig. S1o,p). Taken together, these 
results show that, in mouse postnatal skeletal muscle, AP is only 
expressed by a subset of vessel-associated cells, whereas myogenic 
cells and myo!bres never express AP.
Tissue nonspeci!c alkaline phosphatase CreERT2 mice. #ree 
isoforms of AP have been identi!ed in mouse: the placental (P-AP) 
and the intestinal (I-AP) isoforms on chromosome 1, and tissue 
nonspeci!c AP (TN-AP) on chromosome 4. By RT–PCR with prim-
ers speci!c for the di"erent isoforms20, we found that adult skeletal 
muscle express exclusively TN-AP (Supplementary Fig. S2a). To 
follow the fate of AP +  cells in postnatal skeletal muscle, we gener-
ated three transgenic Tg:TN-AP-CreERT2 mouse lines (#3; #6; #12) 
(Supplementary Fig. S2b,c). A%er crossing with R26R reporter, the 
three transgenic lines express similar e&ciency of Cre recombina-
tion, with little variability among di"erent animals. No signal out-
side AP +  cells was detected in any of the mouse lines. We chose, 
for the majority of subsequent experiments line #12, whose founder 
was more fertile. However, several crucial experiments, such as con-
tribution to muscle !bres, were repeated in the di"erent lines, again 
with similar results.
To examine the e&ciency of recombination during postnatal 
skeletal muscle development, we subcutaneously injected Tg:TN-
AP-CreERT2:R26R mice with tamoxifen for 3 consecutive days 
at P6, P7 and P8, and skeletal muscles were analysed 3 days a%er 
the last injection. Approximately 70% of AP +  vessels also express 
?-gal, indicating e&cient recombination, and no ?-gal + /AP-nega-
tive cells were detected (Fig. 2a). Whole-muscle X-gal staining 
revealed ?-gal +  vessels as expected (Diaphragm and Quadriceps 
muscles are shown in Fig. 2b,c, respectively). Moreover we demon-
strated, on skeletal muscle sections from Tg:TN-AP-CreERT2 mice 
that also carry the R26NZG reporter21, that ?-gal is expressed by both 
Pecam +  endothelial cells (Fig. 2d,e) and PDGFR? +  (Fig. 2f,g) or 
NG2 +  (Fig. 2h–k) pericytes at a ratio of about 1:1 (quanti!cation in 
Fig. 2l: 500 ?-gal +  cells were analysed.). #e same results were con-
!rmed also with Tg:TN-AP-CreERT2:R26R mice. (Supplementary 
Fig. S2d,e). A%er control oil injections no ?-gal signal was detected 
(Supplementary Fig. S2f,g).
To further validate this transgenic mouse model and to unequiv-
ocally rule out that the Cre recombinase might be activated by satel-
lite cells, we prepared single !bres and nonpuri!ed cells suspension 
from skeletal muscle of Tg:TN-AP-CreERT2:R26R-EYFP mice. Both 
preparations were cultured for 5 days with 4-OH tamoxifen: no yel-
low $uorescent protein (YFP) positive cells were found in puri!ed, 
cultured muscle !bres (Fig. 2m,n); whereas in nonpuri!ed primary 
cultures both YFP and MyoD were expressed, but never in the same 
cell (Fig. 2o,p).
By RT–PCR, we showed that freshly isolated YFP +  cells from 
Tg:TN-AP-CreERT2:R26R-EYFP mice (killed 2 days a%er the last 
tamoxifen injection), express TN-AP but not Pax7 and Myf5 mes-
senger RNAs, as opposed to freshly isolated SM/C2.6 +  satellite cells 
from the same mice (Supplementary Fig. S2h). Moreover, quanti-
tative RT–PCR showed that YFP +  cells express high levels of Cre, 
while satellite cells isolated from the same mice do not (Supplemen-
tary Fig. S2i; as positive control, we used C2C12 cells infected with 
recombinant AAV-Cre). #ese results indicate that satellite cells and 
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their derivatives never express the transgenic TN-AP-CreERT2 con-
struct, both in vivo and in vitro.
AP-derived cells contribute to postnatal skeletal muscle. To 
analyse the fate of AP + /?-gal +  cells, Tg:TN-AP-CreERT2:R26R 
mice were genetically labelled as described above and were killed 
8 weeks later, at the end of their growth period. We detected sev-
eral areas with ?-gal +  !bres in all muscles analysed (Quadriceps, 
Gastrocnemius and Biceps femoris muscles are shown in Fig. 3a–c). 
Skeletal muscle sections showed many ?-gal +  muscle !bres together 
with ?-gal +  vessels (Fig. 3d,e) and several ?-gal + /MyHC +  !bres 
(Fig. 3f). ?-gal expression was randomly distributed between 
fast and slow !bres. #e highest percentage of ?-gal +  myo!bres 
(7.3 ? 1.2%) was observed in the Diaphragm whereas the lowest was 
in the TA muscle (0.6 ? 0.2%) (Fig. 3g). We also con!rmed these 
results by assaying ?-gal activity in homogenates from di"erent 
muscles (Methods) (Fig. 3h). Similar results were obtained using 
Tg:TN-AP-CreERT2:R26NZG mice (Fig. 3i, quanti!cation in Fig. 3g), 
where we could clearly detect blue nuclei inside skeletal muscle 
!bres (Fig. 3j,k), ruling out the possibility of nonspeci!c staining 
due to ?-gal di"usion inside the tissue. Tamoxifen injections at P1, 
P2 and P3 resulted in high pup lethality and did not signi!cantly 
increase the percentage of labelled myo!bres, suggesting that the 
contribution of AP-expressing cells to skeletal muscle remains con-
stant in the !rst week of postnatal life. On the other hand, later 
tamoxifen injections, from P8 to 1 month of age, resulted in a pro-
gressively lower amount of ?-gal +  !bres in adult life, indicating 
that the myogenic potential of AP +  cells decreases with subsequent 
mouse growth.
Next, we investigated whether AP +  cells might contribute to 
the satellite cell pool. To this end, muscles of Tg:TN-AP-CreERT2:
R26R mice were collected at di"erent time points a%er tamoxifen 
induction. No ?-gal + /Pax7 +  satellite cells were observed in vivo 
3 days a%er the last tamoxifen injection; moreover, freshly isolated 
AP DAPI
AP DAPI
AP DAPI
AP Pax7 Lam AP Myf5 AP PECAM Myf5 
PDGFR??DAPI
NG2
Pecam?DAPI
SMA DAPI
NG2 DAPI
VE-Cad Merge
Merge
Merge
Figure 1 | AP expression in mouse postnatal skeletal muscle. (a–d) Immunofluorescence analysis on 1-month-old mouse muscle sections shows 
localization of AP within vessel-associated cells. (a) AP +  cells are stained in red, nuclei are stained in blue by DAPI (b) NG2 +  cells are stained in green, 
(c) Ve-Cadherin +  cells are stained in cyan, (d) merged image. (e–h) AP is expressed by PDGFR? + /SMA +  pericytes. (e) AP +  cells are stained in red, 
nuclei are stained in grey by DAPI, (f) PDGFR? +  cells are stained in green, nuclei are stained in grey by DAPI (g) SMA +  cells are stained in blue and  
nuclei in grey by DAPI, (h) merged image. (i–l) AP is expressed by Pecam +  endothelial cells, surrounded by an AP-negative pericyte. (i) AP +  cells are 
stained in red, nuclei are stained in grey by DAPI, (j) Pecam +  cells are stained in green, nuclei are stained in grey by DAPI, (k) NG2 +  cells are stained in 
blue, nuclei are stained in grey by DAPI, (l) merged image. (m) Immunostained TA muscle (15-days-old) shows a Pax7 +  satellite cell (green arrow),  
and an AP +  vessel-associated cell (red arrow); Laminin in magenta. We counted 170 AP + /Pax7 −  cells and 102 AP − /Pax7 +  cells in TA muscle and 438 
AP + /Pax7 −  cells and 138 AP − /Pax7 +  cells in Soleus muscle: no co-localization is detected. (n,o) Myf5nlacZ/ +  TA muscle sections stained for X-gal (blue) 
and AP (red); Pecam is stained brown in (o). (a–d) Scale bar, 100 ?m. (e–o) Scale bar, 20 ?m.
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satellite cells did not express ?-gal activity. However, 1 week a%er 
tamoxifen injection, few double-positive satellite cells were iden-
ti!ed in vivo (Fig. 4a) (0.19% of the total Pax7 +  cells in the TA 
and 2.5% in the Pectoralis). At later stages, the percentage of dou-
ble-positive Pax7 + /?-gal +  satellite cells progressively increased 
in all muscles analysed, reaching, for example, 25% of total Pax7 + 
cells at 1 month a%er tamoxifen injection in the Pectoralis muscle 
(Fig. 4b). An example of Pax7 + /?-gal +  satellite cells underneath 
the basal lamina of a ?-gal-negative !bre is shown in Figure 4c–f. 
Quanti!cations of Pax7 + /?-gal +  satellite cells detected with time 
are shown in Figure 4g. Although the total number of Pax7 +  satel-
lite cells decreases with time, the number of double-positive Pax7 + / 
?-gal +  progressively increases, reaching a plateau at 3 weeks 
a%er tamoxifen induction; a detailed quanti!cation for the Pecto-
ralis muscle is shown in Figure 4h. Interestingly, we found a higher 
number of double-positive Pax7 + /?-gal +  cells in the same muscles 
where we detected more ?-gal +  !bres, suggesting that AP-derived 
cells contribute to skeletal muscle formation mainly by entering the 
satellite cell compartment, although direct fusion with developing 
muscle !bres may occur as well.
Muscle regeneration enhances AP +  pericyte myogenesis. Tg:TN-
AP-CreERT2:R26R mice were treated with tamoxifen at P6–P8 
and then injected with cardiotoxin in TA and Gastrocnemius mus-
cles at P30; three weeks a%er injury all treated muscles showed a 
strong increase in the percentage of ?-gal +  !bres in comparison 
with the contralateral, uninjured muscle (Fig. 5a,b). A section at 
high magni!cation, showing centrally located nuclei, typical of 
regenerating !bres, is shown in Figure 5c; quanti!cation is shown 
in Figure 5d. #ese experiments were con!rmed with Tg:TN-
AP-CreERT2:R26R line #3 and using Tg:TN-AP-CreERT2:R26NZG 
mice (Fig. 5e).
TN-AP-CreERT2:R26R
Diaphragm:
% of ?-gal+ cellsTN-AP-CreERT2:R26 NZG
TN-AP-CreERT2:R26R-EYFP
?-gal AP
?-gal PECAM
?-gal PDGFR?
?-gal NG2 DAPI PECAM DAPI Merge
PDGFR?? DAPI
DAPI MyoD
DAPI MyoD
YFP MyoD
YFP MyoD
PECAM DAPI
Pecam+
47.9%
52.1%
NG2+
Figure 2 | Tg:TN-AP-CreERT2 mouse generation. (a) Section of Diaphragm muscle from double heterozygous Tg:TN-AP-CreERT2:R26R mice stained for 
?-gal (blue) and grey (red) 72 h after tamoxifen injection. Double-positive ?-gal + /AP +  vessels are clearly visible. High magnification in the inset. Scale 
bar, 100 ?m. (b,c) X-gal whole-mount staining of Diaphragm (b) and Quadriceps (c) from Tg:TN-AP-CreERT2:R26R mice, 72 h after last tamoxifen injection. 
(d–k) Tg:TN-AP-CreERT2:R26NZG Triceps muscle sections, 72 h after tamoxifen injection, stained with X-Gal and antibodies specific for the endothelial or 
pericyte lineages. (d,e) Two ?-gal + /Pecam +  endothelial cells are visible (arrows). Pecam is stained in red, nuclei are counterstained with DAPI. Scale 
bar, 20 ?m. (f,g) Two ?-gal + /PDGFR? +  pericytes surrounding a small vessel. PDGFR? is stained in green, nuclei are counterstained with DAPI. Scale bar, 
20 ?m. (h–k) A ?-gal + /NG2 +  pericyte surrounding a small vessel. Note that the pericyte is negative for the endothelial marker Pecam. NG2 is stained in 
green; Pecam in red; nuclei are counterstained with DAPI. Scale bar: 20 ?m. (l) Distribution of ?-gal +  cells within the endothelial and pericyte populations 
for the Diaphragm muscle; 500 ?-gal +  cells were analysed. (m,n) Single fibre preparation from Tg:TN-AP-CreERT2:R26R-EYFP TA muscle cultured for  
5 days with 4-OH tamoxifen and stained with anti-MyoD (red) and anti-GFP antibodies (green); DAPI in blue. No YFP +  cells were found in purified fibre 
preparations. Scale bars, 50 ?m (o,p) Nonpurified cell suspension of TA muscle from Tg:TN-AP-CreERT2:R26R-EYFP mice, cultured for 5 days with 4-OH 
tamoxifen and stained for MyoD (red) and GFP (green); DAPI in blue. Scale bars, 50 ?m.
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To investigate whether AP +  pericyte-derived satellite cells were 
able to support a second round of regeneration, six Tg:TN-AP-
CreERT2:R26NZG mice at 1 month of age were injected with cardio-
toxin in both TA, as described above. A%er three weeks, a second 
cardiotoxin injection (at the same dose) was performed in the right 
TA only. Mice killed 24 h a%er the second injection showed complete 
destruction of previously regenerated !bres (Fig. 5f), as compared 
with contralateral muscles that had received only one injection and 
appeared similar to what shown in Figure 5e. Mice killed a%er three 
extra weeks showed the presence of new ?-gal + , centrally nucleated 
!bres (Fig. 5g).
Muscular dystrophy also enhances AP +  pericyte myogenesis. To 
test whether AP +  pericytes increase their contribution to skeletal 
muscle during the degeneration/regeneration cycles that charac-
terize the progression of muscular dystrophy, Tg:TN-AP-CreERT2:
R26R:?SG − / −  dystrophic pups and their heterozygous littermates 
Tg:TN-AP-CreERT2:R26R:?SG + / −  were injected with tamoxifen 
at P6–P8 and killed 2 months later. In dystrophic skeletal muscle, 
we observed a very high percentage of ?-gal +  !bres, up to three 
times more than control mice (Fig. 6a,b). Skeletal muscle sections 
showed that the regenerated !bres robustly express ?-gal (Fig. 6c; 
quanti!cation in Fig. 6d).
AP +  pericyte myogenesis is minimal in adult muscle. Two- and 
three-month-old male Tg:TN-AP-CreERT2:R26R mice were treated 
intraperitoneally with tamoxifen for 3 consecutive days and, 1 week 
a%er tamoxifen injection, almost 70% of AP +  cells were ?-gal + . 
?-gal expression always co-localized with Pecam +  or NG2 +  vessel- 
associated cells (Supplementary Fig. S3a,b).
Two months a%er tamoxifen injection, all muscles examined 
showed many ?-gal +  vessels; in ~30% of treated mice, we detected 
very few ?-gal +  !bres, only short fragments of which were labelled, 
suggesting focal contribution of few AP-derived cells during adult 
life (Supplementary Fig. S3c). Moreover, this minimal contribu-
tion did not signi!cantly increase a%er cardiotoxin-induced regen-
eration (0.15 ? 0.1 in control TA and 0.93 ? 0.4 in cardiotoxin TA; 
n = 4) (Supplementary Fig. S3e–h; quanti!cation in Supplementary 
Fig. S3d). #e contribution did not increase even when mice were 
injected with tamoxifen for 5 consecutive days.
Endothelial cells do not contribute to postnatal myogenesis. As 
AP is expressed in both pericytes and endothelial cells, we inves-
tigated whether one or both cell types contribute to skeletal mus-
cle formation in vivo. Tg:VE-cadherin-(PAC)CreERT2:R26R mice13 
were injected at P6–P8 with tamoxifen. Because VE-Cadherin is 
expressed only in endothelial cells22, we could selectively follow the 
fate of these cells. #ree days a%er induction, 87 ? 5% of total ves-
sels were ?-gal +  (Fig. 7a) and remained ?-gal +  even in the mouse 
adult life (Fig. 7b,c), indicating a very e&cient recombination in 
this transgenic mouse strain. Neither satellite cells nor myo!bres 
were labelled 3 days or 1 week a%er tamoxifen injection (Fig. 7d) or, 
most importantly, 1 or 2 months a%er tamoxifen injection, in any 
of the muscles analysed (Fig. 7e). #is was also the case a%er mus-
cle regeneration induced by cardiotoxin injection (Fig. 7f,g). Taken 
together, these results indicate that in postnatal life, endothelial cells 
do not contribute to skeletal muscle growth or regeneration, nor to 
the satellite cell pool.
AP +  cells generate smooth or skeletal myogenic clones in vitro. 
To con!rm a possible progressive recruitment of AP +  cells into the 
satellite cell compartment, YFP +  cells, isolated from Tg:TN-AP-
CreERT2:R26R-EYFP mice (Fig. 8a) at di"erent time points (3 days, 
1 week, 1 and 2 months) a%er tamoxifen injection (P6–P8), were 
stained for Pax7 (Fig. 8c–e; quanti!cation Fig. 8b). #e percentage of 
double-positive Pax7 + /YFP +  cells progressively increased during 
the !rst month of life from 0%, 3 days a%er tamoxifen injection, to 
3.7 ? 1.4% a%er 1 week, and 25.7 ? 2.9% a%er 1 month, remaining at a 
similar level at 2 months (30.3 ? 5.2%). One month a%er cardiotoxin 
muscle injury, tamoxifen-treated mice showed a similar percentage 
of YFP +  cells co-expressing Pax7 (29.5 ? 5.4%) (Fig. 8b), suggesting 
that AP-derived satellite cells can self-renew and maintain a con-
stant contribution to the satellite cell pool. #ese results were con-
!rmed by quantitative RT–PCR for Pax7 and Myf5 (Supplementary 
Fig. S4a). Surprisingly, AP-derived satellite cells did not express 
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Figure 3 | Cells derived from TN-AP +  pool contribute to skeletal muscle 
fibre development. (a–c) ?-gal staining of three different muscles,  
2 months after tamoxifen injection: Quadriceps (a) Gastrocnemius (b), 
Biceps femoris (c). (d,e) Quadriceps muscle sections stained for ?-gal; 
blue fibres (arrow) along with blue vessels (arrowhead) are visible. The 
sign ( + ) marks ?-gal +  fibres, whereas the sign ( − ) marks fibres with 
very low or no ?-gal expression. (f) Immunofluorescence on sections 
from the same muscles shown in (d) and in (e) stained with anti- 
?-gal (red), anti-MyHC (green) and anti-Laminin (magenta) antibodies 
confirms the presence of ?-gal positive fibres. Scale bar, 100 ?m.  
(g) Quantification of ?-gal +  fibres counted on the total fibre number. 
Different muscles were analysed. Number of experimental animals:  
n = 15 for Tg:TN-AP-CreERT2:R26R mice, black bars; n = 5 for Tg:TN-AP-
CreERT2:R26NZG, red bars. Error bars represent standard deviation.  
(h) ?-gal activity measurement on muscle homogenates. Standard curve 
was obtained by different dilutions of CMV-Cre-R26 and wt muscles. 
?-gal activity obtained 1 week after the last tamoxifen injection in TN-AP-
CreERT2:R26R mice (representing labelling of the vessels) was subtracted 
from the obtained values. QUA, Quadriceps; GAS, Gastrocnemius; TRIC, 
Triceps; PECT, Pectoralis; DIAPH, Diaphragm; ABD, Abdominal; BICF, Biceps 
femoris. Number of experimental animals: n = 5. Error bars represent 
standard deviation. (i–k) Muscle sections of Tg:TN-AP-CreERT2:R26NZG 
injected with tamoxifen at P6–P8 and killed 2 months later, stained with 
X-gal and Eosin. Arrows show ?-gal +  nuclei inside skeletal muscle fibres; 
arrowhead shows ?-gal +  nuclei of vessel-associated cells. Scale bar, 
100 ?m (i) or 20 ?m (j,k).
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Myf5, suggesting that they may belong to the Pax7 + /Myf5 − , self-
renewing satellite cell population23.
To test the skeletal myogenic potential of AP-expressing vas-
cular progenitors, we analysed the ability of AP-derived cells to 
give rise to myogenic clones. YFP +  cells were isolated 1 week a%er 
tamoxifen induction (P6–P8) and plated at clonal density in 96 
multiwells (1 cell per well). On average, 10% of plated cells gave 
rise to clones and 30% of these clones contained MyHC-expressing 
myocytes and myotubes (Fig. 8f), indicating that AP-Cre + , vessel-
associated cells have a signi!cant spontaneous myogenic potential 
a%er isolation. Most ( > 90%) of the remaining MyHC-negative 
clones expressed smooth muscle actin (SMA) (Fig. 8g), in agree-
ment with their pericyte origin and smooth muscle fate. #is was 
con!rmed by staining with an antibody recognizing the cytoskel-
etal protein SM22?, a smooth muscle-speci!c marker24 (Fig. 
8h); very few clones (less than 1%) contained both MyHC +  and 
SM22? +  cells (Fig. 8i), indicating that very few AP +  cells main-
tain a double potency, once isolated and cloned in vitro. Freshly 
isolated YFP +  cells express pericyte and endothelial genes such 
as Tie2, (endothelial-speci!c receptor tyrosine kinase 2), VEGFR2 
(vascular endothelial growth factor receptor 2), AnnexinV, SMA 
and PDGFR? (Supplementary Fig. S4b) and, on in vitro culture, 
YFP +  cells maintain pericyte markers such as NG2, SMA and 
desmin (Supplementary Fig. S4c–e).
To further investigate the myogenic di"erentiation process of 
AP-derived pericytes and its relation with muscles expressing Pax3 
in vivo, we sorted YFP +  cells from forelimb muscles (whose sat-
ellite cells are known to express Pax3) and hindlimb muscles of 
Tg:TN-AP-CreERT2:R26R-EYFP mice, either 1 and 8 weeks a%er 
last tamoxifen injection. At di"erent times in culture, we followed 
Pax7, Pax3 and Myf5 expression by immuno-$uorescence. A high 
percentage of YFP +  cells, sorted 1 week a%er last tamoxifen injec-
tion, was found to express Pax3; 60% of the total YFP +  cells from 
the forelimb, and 25% from hindlimb (Supplementary Fig. 5a–c). 
Pax3 expression rapidly decreases a%er 48 h in culture, when Myf5 
expression !rst appears. Pax7 is never expressed in culture, indi-
cating that the myogenic di"erentiation of AP-derived pericytes, 
in culture, is Pax7-independent (Supplementary Fig. S5d–f). On 
the other hand, the protein expression pro!le of YFP +  cells sorted 
from Tg:TN-AP-CreERT2:R26R-EYFP, 8 weeks a%er last tamoxifen 
injection, is di"erent and comparable to the typical satellite cells 
pro!le. In fact, Pax7 is expressed in many cells (50%) until 72 h 
in culture and decreases therea%er with a concomitant increase of 
Myf5 expression (Supplementary Fig. S5g–i) At this stage Pax3 is 
present at a low frequency (below 10%) only in cells obtained from 
forelimb muscles. Quanti!cation of myogenic gene expression 
in YFP +  cells during time in culture, is shown in Supplementary 
Figure S5j,k, respectively, 1 week or 8 weeks a%er tamoxifen injec-
tion. Direct quantitative comparisons between Pax3 and Pax7 is not 
possible since Pax3 is also expressed in some smooth muscle cells25 
whereas Pax7 is not. In both cases, YFP +  cells, obtained 1 week or 
8 weeks a%er tamoxifen injection, begin to form myotubes a%er 5 
days in culture. Each experiment was repeated three times with six 
mice each; polyclonal populations were analysed a%er 24 and 48 h 
in culture, whereas single cell-derived clones were analysed at later 
time points, when clones became clearly identi!able.
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Figure 4 | Generation of satellite cells from AP + -derived cells during mouse growth. (a) Immunohistochemistry on Tg:TN-AP-CreERT2:R26R Pectoralis 
muscle sections, 1 week after tamoxifen injection, stained for ?-gal (blue) and anti-Pax7 (brown). The majority of Pax7 +  cells are ?-gal negative  
(brown arrows), whereas vessels are blue (blue arrows). Only few double-positive cells are detectable (green arrow). Insets show high magnification. 
(b) Immunohistochemistry on Tg:TN-AP-CreERT2:R26R Pectoralis muscle sections 1 month after last tamoxifen injection stained for ?-gal (blue) and Pax7 
(brown). Several Pax7 + /?-gal +  satellite cells were detected (green arrows) together with ?-gal +  fibres. Insets show high magnification. (c–f) TA muscle 
section of Tg:TN-AP-CreERT2:R26R mouse, 2 months after tamoxifen injection. A Pax7 +  (green) satellite cell also expresses ?-gal (red) (arrows); the 
satellite cell is associated to a ?-gal-negative fibre. Laminin is stained in magenta. Scale bar, 100 ?m. (g) Pax7 + /?-gal +  satellite cells counted on the total 
number of Pax7 +  satellite cells, in different muscles and at different time points after tamoxifen induction: 1 week (pale blue), 2 weeks (dark blue),  
3 weeks (pale grey), 4 weeks (dark grey). Number of experimental animals: n = 5. Error bars indicate standard deviation. Results were assessed for 
statistical significance by Student’s t-test (unpaired, two-tailed) and differences were considered statistically significant at P < 0.05. Asterisks in the 
histogram indicate the different P values: **P < 0.01 and ***P < 0.001. (h) Total number of satellite cells for microscopic field (~0.5 mm2) at different time 
points after tamoxifen induction in Pectoralis muscle. Blue bars indicate the number of Pax7 + /?-gal −  satellite cells; red bars indicate the number of 
Pax7 + /?-gal +  satellite cells. The total number of Pax7 +  cells decreases with time, whereas the number of double-positive Pax7 + /?-gal +  cells increases 
until 3 weeks after tamoxifen induction, remaining constant afterwards. Number of experimental animals: n = 5. Error bars indicate standard deviation. 
Results were assessed for statistical significance by Student’s t-test (unpaired, two-tailed) and differences were considered statistically significant at 
P < 0.05. Asterisk in the histogram indicates P value: *P < 0.05.
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Discussion
Postnatal myogenesis is mainly due to proliferation of juvenile 
satellite cells that contribute to the development of skeletal mus-
cle by fusing with growing myo!bres, and, to its regeneration, 
by repairing or replacing damaged or degenerated myo!bres26. 
Nevertheless, in the last ten years, evidence has accumulated that 
other progenitors can contribute to skeletal muscle regeneration 
either by direct fusion or by entering the satellite cell pool6–8,27–36. 
When identi!ed, the anatomical niche of these cells has been o%en 
associated with blood vessels (endothelial cells, pericytes and also 
haematopoietic cells). However, the embryonic origin of these 
unorthodox myogenic cells and their lineage relationship with 
satellite cells remain unknown. It was similarly unclear whether 
skeletal myogenesis is one possible developmental option of these 
non-myogenic progenitors, or whether it represents the arti!-
cial consequence of cell transplantation that, through occasional 
fusion with regenerating !bres, exposes the donor cell nucleus to 
the dominant e"ect of MyoD.
In this work, we used Tg:TN-AP-CreERT2 mice to follow the 
fate of vessel-associated cells during postnatal muscle growth. AP 
is broadly expressed in many pre- and postnatal tissues, and in dif-
ferent cell types such as osteoblasts37, embryonic stem cells38, bone 
marrow stroma cells39, liver and kidney cells40, granulocytes41 and B 
cells42; however, in postnatal mouse striated muscles, AP is expressed 
only by vessel-associated cells, in both endothelial cells and peri-
cytes, as previously reported9,14–16, and exhaustively con!rmed 
in this work through a variety of histochemical and immuno-
chemical methods. Most importantly, by using virtually all possi-
ble experimental approaches, we demonstrated that both AP and 
Cre expression are invariably absent in quiescent satellite cells, as 
well as in proliferating and di"erentiating myogenic cells in vitro 
or in vivo, even a%er cardiotoxin-induced damage. #ese prelimi-
nary results rule out the possibility of inappropriate lineage tracing, 
because of undetected expression in di"erent cell types resident in 
skeletal muscle, and allowed us to investigate the fate of AP-derived 
vascular cells in growing postnatal skeletal muscle. A time course 
of reporter gene expression showed that, beside their expected con-
tribution to the micro-vascular wall, pericytes, but not endothelial 
cells (as revealed by an endothelial-speci!c CreERT2 mouse), con-
tribute to the growth of a minor but signi!cant percentage of mus-
cle !bres. Moreover, many AP-derived cells enter the satellite cell 
pool, with a relatively fast kinetics during the !rst month of post-
natal life, suggesting that they also contribute to subsequent muscle 
regeneration. Indeed, conditions that trigger acute or chronic skel-
etal muscle regeneration, such as cardiotoxin injection or muscular 
dystrophy, increase dramatically AP +  cell contribution to skeletal 
myogenesis (up to !ve times in the area of acute regeneration and 
three times in dystrophic muscle). #ese results show that AP + 
pericytes respond to pathological conditions, and, thus, they may 
serve as a tool for the cell therapy of dystrophic patients and justify 
the rationale for a clinical trial, with human AP +  pericytes, that is 
currently running in our Institution.
We found the highest number of ?-gal +  !bres and ?-gal +  sat-
ellite cells in muscles where Pax3 is expressed postnatally, such as 
forelimb muscles and Diaphragm43. Furthermore, we observed that 
these AP +  vessel-associated cells express Pax3 in young animals 
(D.A., C.D. and C.G.; unpublished data) and that YFP +  cells, iso-
lated 1 week a%er tamoxifen injection, express Pax3, and not Pax7, 
in culture. On the other hand, we have clearly shown that, during 
mouse growth, AP-derived pericytes become real satellite cells and 
acquire Pax7 +  expression in vivo, under the basal lamina and when 
isolated in vitro, two months a%er tamoxifen induction. It was previ-
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Figure 5 | AP +  pericytes contribution to skeletal muscle after acute injury. (a,b) Whole-mount X-Gal staining of Tg:TN-AP-CreERT2:R26R untreated 
(a) or cardiotoxin-treated (b) TA muscle showing a dramatic increase in the number of ?-gal + , regenerated fibres. (c) Section of muscles shown in (b), 
stained for ?-gal and H&E; ?-gal +  centrally nucleated fibres are visible. (d) The percentage of ?-gal +  fibres is increased from 0.9% in untreated TA muscle 
(grey histogram) to 5.07% in cardiotoxin-treated TA muscle (black histogram). In Gastrocnemius (GAS), the percentage of ?-gal +  fibres is increased from 
1.6% in untreated leg (grey histogram) to 11.15% in cardiotoxin-treated (black histogram). Number of experimental animals: n = 5; error bars indicate 
standard deviation. Results were assessed for statistical significance by Student’s t-test (unpaired, two-tailed) and differences were considered statistically 
significant at P < 0.05. Asterisks in the histogram indicate the different P values: **P < 0.01 and ***P < 0.001. (e) TA section of Tg:TN-AP-CreERT2:RNZG mice 
injected with tamoxifen at P6–P8, treated with cardiotoxin at 3 weeks and killed 3 weeks after damage. Many regenerating, centrally nucleated fibres are 
present (arrows); high magnification is shown in the inset. (f,g) TA sections of Tg:TN-AP-CreERT2:RNZG mice injected with two rounds of cardiotoxin and 
killed 24 h (f) or 3 weeks (g) after the second injury (details in the text). Scale bar, 100 ?m.
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ously demonstrated that during embryogenesis Pax3 +  progenitors 
of the dermomyotome give rise not only to myogenic cells, but also 
to several other mesoderm cell types, including dermal !broblasts, 
endothelial cells44,45, and, notably, to pericytes and smooth muscle 
of the dorsal aorta25. #us, whereas all satellite cells appear to origi-
nate from somites2, the data presented here are not in contrast with 
this evidence, because other mesoderm progenitors, such as Pax3-
expressing pericytes, also originate from somites. #ese progenitors 
may directly di"erentiate into skeletal muscle while expressing Pax3 
(at least in vitro), and this occurs more frequently in postnatal fore-
limb muscles where Pax3 is more abundant; alternatively, they may 
enter the satellite cells pool and activate Pax7 expression.
AP +  cell contribution to skeletal muscle mainly occurs during 
the !rst month of postnatal growth and becomes sporadic in adult 
mice even in regenerating myo!bres a%er cardiotoxin-induced 
muscle damage. Probably only during perinatal growth AP-derived 
pericytes can contribute to skeletal myogenesis and enter the 
satellite cells pool, in response to a major recruitment of myogenic 
cells to the maturing muscle !bres. #us, it is conceivable that this 
contribution may be higher during prenatal development but, 
unfortunately, widespread expression of AP at this stage precludes 
this analysis.
Very recently, three reports46–48 showed that selective ablation 
of Pax7-expressing satellite cells during adult life permanently 
hampers subsequent attempts to regenerate skeletal muscles, 
leading to the conclusion that no other endogenous cell types may 
substitute for satellite cells. #ese results are not in contradiction 
with those reported here for the following reasons: the ablation 
of Pax7 +  satellite cells was carried out in adult mice, at an age 
when the contribution of AP +  pericyets to muscle regenera-
tion becomes negligible. It is also possible that satellite cells are 
required to induce other cell types to adopt a myogenic fate, as 
suggested by Sambasivan et al.48
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Figure 6 | AP +  pericytes contribution to skeletal muscle during chronic 
regeneration. (a,b) Triceps muscles of Tg:TN-AP-CreERT2:R26R:?SGKO  
(a) or Tg:TN-AP-CreERT2:R26R:?SG + / −  (b) mice, injected with tamoxifen 
at P6–P8, killed two months later and stained for ?-gal activity. Many  
?-gal +  fibres can be detected in the dystrophic muscle. (c) Muscle 
sections of Tg:TN-AP-CreERT2:R26R:?SGKO shown in (a) stained for ?-gal 
and H&E. Scale bar, 100 ?m. (d) Percentage of ?-gal +  fibres detected in 
the dystrophic muscles. Grey bars indicate ?SG + / −  background; black 
bars indicate ?SGKO background. Number of experimental animals: n = 5; 
error bars indicate standard deviation. Results were assessed for statistical 
significance by Student’s t-test (unpaired, two-tailed) and differences were 
considered statistically significant at P < 0.05. Asterisks in the histogram 
indicate the P value: ***P < 0.001. GAS, Gastrocnemius; TRIC, Triceps; PECT, 
Pectoralis; DIAPH, Diaphragm.
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Figure 7 | Endothelial cells do not contribute to growing or regenerating muscle. (a) Ve-cadherin(PAC)-CreRT2:R26R Pectoralis muscle stained for ?-gal 
(blue) and Pecam (brown) 3 days after tamoxifen injections (P6–P8). (b,c) Whole mount X-Gal staining of Ve-cadherin(PAC)-CreRT2:R26R Diaphragm (b) 
and Pectoralis (c) 2 months after tamoxifen injections (P6–P8). ?-gal +  vessels are clearly visible. (d,e) TA muscle sections of Ve-cadherin(PAC)-CreERT2:
R26R mouse 1 week (d) and 2 months (e) after tamoxifen injection, stained for ?-gal (blue) and anti-Pax7 (brown). No double-positive cells are present.  
(f,g) TA muscle sections of Ve-cadherin(PAC)-CreERT2:R26R mice 1 month after cardiotoxin injection (CTX) (g) and contralateral muscle (f), stained for 
?-gal and H&E. No ?-gal +  fibres are detected. Scale bar, 20 ?m.
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In conclusion, we have demonstrated that vascular pericytes, 
resident in skeletal muscle, are bi-potent (as con!rmed by clonal 
analysis), as they contribute to both the smooth muscle layer of 
blood vessels and skeletal muscle !bre development, including 
the satellite cell pool, during unperturbed, postnatal growth of 
the mouse. It is still unknown how this choice is regulated in vivo, 
although it is plausible that signals emanating from neighbour 
muscle !bres or endothelium may direct the cells to a skeletal or to 
a smooth muscle fate, respectively.
Methods
Mice generation and genotyping. To generate Tg:TN-AP-CreERT2 mice the Cre 
recombinase fused with estrogen receptor (CreERT2) was cloned in a pGEM-T Easy 
Vector, between two fragments homologous to TN-AP gene in the starting coding 
region ATG upstream region. #e construct was inserted into a bacterial arti!cial 
chromosome (BAC) 240 kbp clone (RP23 RP23-400F8 (Start: 137,302,861 and End: 
137,529,460)) by homologous recombination in bacteria (spanning from 177 kbp 
upstream of the ATG, and covering most of the coding region). Molecular analysis dem-
onstrated the correct insert of the construct into the BAC (Supplementary Fig. S2b,c). 
Digestion by BamHI shows the generation of an extra 2.8 kbp band and the absence 
of an 8 kbp band in the electroporated BAC compared with the unelectroporated 
one. Injection of the BAC into fertilized eggs generated a total of seven independent 
transgenic lines that were tested by crossing with the R26R reporter mouse49. #ree lines 
were found to express beta-galactosidase and were used for subsequent experiments.
Mice were kept heterozygous and genotyped by FW primer mapping on TN-AP 
sequence (FWTN-AP cgtctagatgagcctagggctggctggagcacag) and RW primer map-
ping on Cre sequence (RWCRE cagccaccagcttgcatga), generating a 1,400 bp band.
Genotyping strategies of other mice, including Pax7 − / −  mutant mice50, 
Myf5nlacZ/ +  mice19, Ve-Cadherin-(PAC)CreERT2 (ref. 12), TN-AP?geo/ +  (ref. 16) have 
been published. To test our transgenic model, we used three di"erent reporter 
mice: R26R49 that express cytoplasmic ?-gal; R26NZG21 that express nuclear ?-gal and 
R26R-EYFP 51 that express cytoplasmic YFP. Control mice C57/BLJ6 from Jackson 
laboratory were used. All experiments were performed under internal regulations 
for animal care and handlings (IACUC 355). Both males and females were used for 
experiments and they were equally distributed between control and treated groups 
to avoid gender variations in muscle mass.
Tamoxifen injection and cardiotoxin treatment. Young animals were injected 
subcutaneously with 0.25 mg of tamoxifen, diluted in corn oil, (SIGMA T5648-1G) 
for 3 consecutive days at 6, 7 and 8 days a%er birth. Adult animals were treated for 
3 consecutive days with 2 mg of tamoxifen by intraperitoneal injection. For the 
injury protocol, 25 ?l of 100 ?M cardiotoxin from Naja mossambica mossambica 
(SIGMA C9759) were injected directly into skeletal muscle.
X-gal staining and immunohistochemistry. Dissected muscles were !xed with 
paraformaldehyde (PFA) 4% and 0.25% glutaraldehyde for 30 min at 4 °C. A%er 
incubation in X-gal solution O/N at 37 °C, they were washed and dehydrated 
with increasing sucrose concentration (10–20 and 30%) for 20 min and then  
frozen within OCT. Eight ?m cryostats sections were used for immunohisto-
chemistry and stained with H&E when necessary. #e endogenous peroxidases 
were blocked by H2O2 30% in methanol for 30 min. #e sections were then incu-
bated with PBS 0.2% Triton 1% BSA for 30 min and with 10% donkey serum for 
30 min. Primary antibody incubation was followed by secondary biotinilated an-
tibody (Dako) and ABC kit (Vector Laboratories, PK-6100), enzymatic reaction  
with DAB (Sigma) was followed under microscope and stopped a%er the  
appropriated time.
?-gal activity measurement. Muscles were homogenized in bu"er (0.25 M Tris 
pH 7.8, PMSF 1 mM), centrifuged at 15,000 g×10 min at 4 °C, and extracted pro-
teins were subsequently quanti!ed by spectrophotometer with DC protein Assay 
(Biorad, 500-0114). 100 ?g of protein were incubated with 500 ?l of Z Bu"er pH7 
(60 mM Na2HPO4 40 mM NaH2PO4 10 mM KCl, 1 mM MgSO4, 50 mM b-Mercap-
toethanol) and 100 ?l of ONPG (o-nitrophenyl-b-d-galactoside) 4 mg ml − 1 at 37 °C 
for 2.5 h. #e reaction was blocked with 250 ?l of Na2CO3 and the level of ?-gal 
activity was evaluated by reading the OD420 at the spectrophotometer. To quantify 
the proportion of ?-gal +  !bres in di"erent muscles of Tg:TN-AP-CreERT2:R26R 
mice, we created a standard curve by mixing di"erent proportions (from 0.1 to 
50%) of muscle homogenates derived from wild-type and CMV-Cre-R26 mice. 
#e proportion of ?-gal activity only due to ?-gal-positive !bres was calculated by 
subtracting the activity measured in muscles from Tg:TN-AP-CreERT2:R26R mice 
injected with tamoxifen and killed 1 week later, when the ?-gal signal is present 
only in vessel-associated cells.
Alkaline phosphatase reaction. Di"erent kits for AP enzymatic detection were 
used (see below) to exploit di"erent reaction colours. Muscle sections were !xed 
with PFA 4% at 4 °C for 10 min and, a%er 3 washes, incubated with BCIP-NBT kit 
(Roche, 12296226 and 12329020) in an alkaline bu"er (NaCl 100 mM, Tris 100 mM 
PH 9.5, MgCl2 50 mM, Tween 0.1%) for 20 min in the dark, or with PermaRed/AP 
(Histo-Line laboratories, K049) for 20 min. Moreover, AP substrate kit from Vector 
(SK-5100) were used and visualized by confocal microscopy (Leica) at 456 nm, 
along with other immuo$uorescent antibodies.
Immunofluorescence and antibodies. Frozen sections and cultured cells were 
!xed with PFA 4% at 4 °C for 10 min, washed 3× with Triton 0.2% BSA 1% in PBS, 
and incubated with the same bu"er for 30 min, followed by 10% Donkey serum for 
30 extra min. Primary antibody was incubated for 1 h at room temperature or O/N 
at 4 °C in the same bu"er. Samples were washed 3 times and then incubated with 
secondary antibodies (Alexa Fluor 488-594-546 or 647, Invitrogen) for 1 h at RM, 
washed 3 times and then mounted and examined under epi$uorescence or  
confocal Leica microscope.
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#e immuno$uorescence assay was carried out with the following antibodies: 
rabbit anti-?-galactosidase at 1:100 dilution (Chemicon, AB986), rabbit anti-?-gal 
at 1:1,000 (MPCappel 559762) and mouse anti-?-gal at 1:200 (Promega Z3783);  
rabbit anti-laminin at 1:300 (Sigma, L9393) or chicken anti-laminin at 1:500 
(Abcam, Ab14055); anti- NG2 1:200 (Chemicon, AB5320) or donated from  
W. Stallcup, at 1:100; anti-Pecam at 1:2 (gi% from Elisabetta Dejana); anti-Pax7 
at 1:2 (DHSB); anti-smooth muscle actin at 1:200 (Sigma, A2547); anti-SM22? 
at 1:100 (Abcam); anti-MyHC at 1:2 (MF20 DHSB); anti-GFP 1:300 (Chemicon, 
AB3080); anti-Ki67 at 1:500 (Novo Castra, NCL-Ki67p), anti-PDGFR? at 1:100 
(from W. Stallcup), anti-AP at 1:100 (R&D); anti Pax3 at 1:2 (DHSB); anti MyoD at 
1:100 (Dako).
Cell sorting. Dissected muscles were cut in small pieces and digested by colla-
genase D 0.1% (Roche, 1088866) and Trypsin 0.25% (Gibco, 15090-046) for 20 min 
at 37 °C, 2 or 3 cycles. A%er spin and !ltration, the cells were collected in DMEM, 
20%FBS, 2 mM EDTA, 20 mM HEPES or PBS 2% FBS, 2 mM EDTA when staining 
with SM/C2.6 (a gi% from S. Takeda).
Cell Sorting was carried out in MoFLo System (DAKO); sorted cells were  
either cloned in 96 wells or collected for RNA extraction. FACS analysis was  
performed by Canto (BD); data were analysed by FACSDiva so%ware (BD).
Sorted cells were cultured with DMEM (Sigma) 20%FBS on (low factor) 
Matrigel (BD, 354248) coated wells, in low (3%) oxygen incubator.
RT–PCR and quantitative real-time PCR. #e RNA from sorted cells was collect-
ed by RNeasy mini (or micro) kit (Qiagen, 74104 and 74004) and converted into 
double-strand complementary DNA with the Superscript VILO cDNA systhesis kit 
(Invitrogen, 11754-050), according to the manufacturer’s instructions. Real-time 
quantitative PCR analysis was carried out on cDNA from isolated cells by using 
an Mx3000P real-time PCR detection system (Stratagene). Each cDNA sample 
was ampli!ed in duplicate by using the Express SYBR GreenER qPCR Supermix 
(Invitrogen, 11784-200). 
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SUMMARY 
 
Nuclear factor I X (Nfix) is a key regulator of fetal myogenesis acting both as an 
activator of fetal-specific genes and as a repressor of embryonic muscle genes, such 
as MyHC-I. Here we show that Sox6, belonging to the Sox factors family, cooperates 
with Nfix in fetal muscle to repress MyHC-I at the transcriptional level. Sox6 and 
Nfix are co-expressed in fetal myoblasts and co-immunoprecipitate in muscle cells. 
By ChIP assay, we show that Nfix is required for Sox6 binding to the MyHC-I 
promoter in fetal myoblasts and thus for Sox6 repressive activity. Moreover, we show 
that Sox6 is a direct activator of MyHC-I in embryonic muscle and is required for 
proper Nfix function in fetal muscle. These data demonstrate functional cooperation 
of Sox6 and Nfix in the regulation of embryonic muscle genes, that is evolutionary 
conserved in mouse and zebrafish. 
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INTRODUCTION 
 
Adult skeletal muscle is composed of two major fiber types presenting a wide range 
of physiological and biochemical differences. Slow-twitch type I fibers use oxidative 
metabolism and express the slow myosin heavy chain (MyHC) isoform (MyHC-I, 
encoded by the Myh7 gene); in contrast, fast-twitch type II fibers present glycolytic or 
mixed metabolism and express three fast MyHC isoforms (MyHC-IIa, IIx/d, and IIb, 
encoded by Myh2, Myh1 and Myh4 respectively) (Peter et al. 1972; Schiaffino et al. 
1988; Chakkalakal et al. 2012). The phenotype of adult muscle fibers is strictly 
regulated by extrinsic signals such as muscle activity and hormones (Ogata et al. 
2005; Mendler et al. 2008). In recent years, many key factors controlling adult muscle 
diversity and plasticity have been identified, including the NFATc transcription factor 
family (Calabria et al. 2009), Wnt3a and BMP4 (Kuroda et al. 2013) and class II 
HDACs (Potthoff et al. 2007). However, the molecular mechanisms by which muscle 
fiber diversity is achieved during development are still unclear. 
In vertebrates the process of skeletal muscle development occurs in subsequent steps 
that involve distinct populations of myogenic progenitors, named myoblasts, which 
arise from the dermomyotomal domain of somitic mesoderm (Christ & Ordahl, 1995). 
The process of myogenic differentiation is initiated in mesodermal cells by a family 
of bHLH transcription factors named Muscle Regulatory Factors (MRFs) able to 
activate transcription of muscle-specific markers such as the MyHC isoforms (Pinney 
et al. 1988; Cao et al. 2010). ‘Embryonic’ myoblasts sustain a first wave of 
differentiation between embryonic day (E) 10 and E12 in the mouse and give rise to 
primary myofibers that establish the primitive shape of muscle and express high 
levels of MyHC-I and of the embryonic MyHC isoform (MyHC-emb, encoded by 
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Myh3) (Schiaffino et al. 1986; Stockdale et al. 1992). A second wave of muscle 
differentiation takes place between E15 and E18, driven by fetal myoblasts that form 
secondary fibers, which are characterized by low levels of MyHC-I and high levels of 
neonatal MyHC (MyHC-neo, encoded by Myh8) (Eusebi et al. 1986; Lyons et al. 
1990; Daou et al. 2013). Eventually, primary fibers conserve the slow-twitch 
phenotype typical of embryonic muscle, while secondary fibers lose the expression of 
several embryonic-specific markers such as MyHC-I and acquire expression of fast-
twitch markers such as muscle creatine kinase (MCK) and the glycolytic enzyme β-
enolase (Eno3) (Ferrari et al. 1997; Biressi et al. 2007). Embryonic and fetal 
myoblasts, once isolated from the embryo, are committed to a specific fiber type, 
suggesting the involvement of intrinsic factors rather than nerve activity in the 
establishment of fiber phenotype (Page et al. 1992). These observations suggest that 
the proper transition of skeletal muscle from the embryonic to the fetal/post-natal 
phenotype requires a switch in the transcriptional status of differentiating myoblasts.  
In a previous study (Messina et al. 2010) we have shown that the transcription factor 
Nfix, member of the nuclear factor I family, has a key role in the establishment of 
fetal muscle phenotype. Nfix is drastically up-regulated in fetal compared to 
embryonic myoblasts and it acts as an indirect repressor of MyHC-I by transcriptional 
inhibition of NFATc4. Moreover, Nfix activates the expression of the fetal-specific 
markers Eno3 and MCK by direct regulation of their promoters. Notably, a recent 
study focused on the zebrafish (Danio rerio) ortholog nfixa (Pistocchi et al. 2013) 
suggests an evolutionary conserved role for Nfix in the transition from slow-twitch to 
fast-twitch myogenesis.  
In the last years it was reported that Sox6, a member of the Sry-related HMG box 
(Sox) factors family highly conserved in vertebrates, plays a critical role in normal 
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fetal fiber specification. In particular Sox6 null mouse muscle displays increased 
levels of MyHC-I and a general switch toward a slower phenotype (Hagiwara et al. 
2007; An et al. 2011). Moreover, several studies have shown that the zebrafish 
ortholog sox6 has a conserved function in repressing slow-twitch genes (such as the 
slow MyHC isoform smyhc1 and the transcription factor prox1a) during embryonic 
muscle development (von Hofsten et al. 2008; Wang et al. 2011). Here we show that 
Sox6 forms a complex with Nfix in fetal muscle cells to cooperatively repress MyHC-
I. Nfix is required for the proper binding of Sox6 to the MyHC-I promoter in fetal 
myotubes. Notably, during embryonic myogenesis Sox6 acts as an activator rather 
than a repressor of MyHC-I. On the other hand, Nfix transcriptional activity during 
fetal myogenesis is severely altered in the absence of Sox6. Finally, we demonstrate 
that Nfixa and Sox6 functionally cooperate in repressing slow-twitch genes in 
zebrafish embryos, revealing an evolutionary conserved mechanism that is required 
for the acquisition of normal muscle phenotype. 
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RESULTS 
 
Sox6 is equally expressed but differentially localized during pre-natal muscle 
development  
As previously reported (Hagiwara et al. 2007; An et al. 2011; Quiat et al. 2011) Sox6 
is a key repressor of the slow/embryonic muscle phenotype. However, a detailed 
characterization of Sox6 expression during the different myogenic waves has never 
been conduced. We first investigated whether Sox6 was differentially expressed in 
muscle progenitors during primary and secondary myogenesis: to this aim Myf5GFP-P/+ 
embryos were collected at E12.5 or E16.5 and GFP positive myoblasts were isolated 
via fluorescence activated cell sorting (FACS) as previously described (Messina et al., 
2010). We interestingly found by quantitative Real Time PCR (qRT-PCR) that Sox6 
mRNA levels do not significantly change between the two populations, whereas Nfix 
is drastically up-regulated in fetal progenitors (Fig. 1A). Moreover, we found no 
differences in Sox6 protein content between freshly isolated embryonic and fetal 
myoblasts (Fig. 1B), confirming that Sox6 is equally expressed in these two 
populations of muscle progenitors. Importantly, these data also show that Sox6 and 
Nfix proteins are co-expressed in fetal myoblasts. We then performed extensive 
immunofluorescence analysis on frozen mouse embryo sections from E11.5 to E18.5 
in order to follow Sox6 protein expression in muscle cells and muscle fibers 
throughout development. We found that Sox6 is expressed at high levels in skeletal 
muscle starting from E12.5: at this stage we found Sox6 positive cells in all the 
embryonic muscle groups, including thoracic, appendicular and dorsal muscles (data 
not shown). Importantly, the subcellular localization of Sox6 protein at this stage is 
mostly cytoplasmic, as revealed by co-localization between Sox6 and total MyHC 
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stained with the MF20 antibody (Fig. 1C-F). We also performed immunofluorescence 
for Sox6 and MyoD or for Sox6 and myogenin (Myog) on E12.5 frozen muscle 
sections (Supplemental Fig. S1A-H): in both cases we found the same cytoplasmic 
staining observed in the majority of MyHC positive cells, suggesting that Sox6 is 
preferentially localized in the cytoplasm of embryonic myoblasts and myocytes in 
vivo. This expression pattern is maintained in all muscle groups until E15.5 (data not 
shown). Then, starting from E16.5, when the initial diversification between primary 
and secondary fibers occurs, the staining for Sox6 is mainly found in the nuclei of 
MyHC positive fibers (Fig. 1G-J), even if a lower staining can still be detected in the 
cytoplasm. We quantified the results obtained by immunofluorescence counting the 
number of nuclear or cytoplasmic Sox6 expression events on the total number of 
Sox6/MyHC double positive cells. As shown in Fig. 1K, the percentage of nuclear 
Sox6 positive cells dramatically increases from 19±8% in the embryonic period to 
69±3% in the fetal period. Conversely, the percentage of cytoplasmic Sox6 positive 
cells decreases from 81±3% to 31±4% in the fetal period. In order to exclude the 
possibility of unspecific staining, we isolated nuclear and cytoplasmic protein 
fractions directly from embryonic and fetal muscle tissue and revealed Sox6 
localization by Western Blot (Fig. 1L). Results show a marked increase of nuclear 
Sox6 and a consequential decrease of cytoplasmic Sox6 in fetal compared to 
embryonic muscle. Interestingly we observed an upper band (marked by the asterisk 
in Fig. 1L) that is highly enriched in the E16.5 nuclear extract, suggesting that Sox6 
may be regulated by post-translational modifications during muscle development. 
Importantly, our Western Blot analysis clearly indicates that Sox6 protein is also 
present in the nuclei of embryonic muscle tissue, even if at a lower level compared to 
fetal muscle. Thus, low levels of Sox6 in the majority of embryonic muscle nuclei are 
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likely undetectable by immunofluorescence. Taken together, these results demonstrate 
that Sox6 is localized in both the cytoplasm and the nuclei of myogenic cells during 
the embryonic period, and it is then rapidly accumulated into the muscle fiber nuclei 
during fetal myogenesis. Strikingly, starting from E17.5 the nuclear expression of 
Sox6 becomes restricted to secondary fibers that are negative for MyHC-I 
(Supplemental Fig. S1I-L), as previously described (An et al. 2011; Richard et al. 
2011). 
 
Sox6 is an activator of MyHC-I during embryonic myogenesis 
Since Sox6 protein is expressed in myocytes from the beginning of embryonic 
myogenesis, we decided to investigate on its possible function during the embryonic 
period, when Nfix is normally expressed at very low levels (Messina et al. 2010). To 
this aim, we performed immunofluorescence analysis on E12.5 muscle sections from 
homozygous mice carrying the Sox6lacZ allele (hence referred to as Sox6 null mice) 
(Smits et al. 2001). Surprisingly, the staining for MyHC-I is strongly decreased in 
Sox6 null in comparison to wild type (wt) muscle (Fig. 2A,B), in a way that is 
reminiscent of the Tg:Mlc1f-Nfix2 Nfix gain-of-function embryo, in which the Nfix2 
isoform is ectopically expressed in muscle cells from E11.5 recapitulating the 
expression pattern of the Myl1 enhancer Mlc1f (Kelly et al. 1997; Messina et al. 
2010) (Fig. 2C). Notably, MyHC-I expression in the embryonic heart is not affected, 
suggesting that MyHC-I down-regulation is restricted to skeletal muscle. Moreover, 
no differences in total MyHC content were assessed in embryonic muscle groups of 
both Sox6 null and Tg:Mlc1f-Nfix2 embryos (Fig. 2D-F), suggesting that the decrease 
in MyHC-I expression is not due to delayed or aberrant muscle differentiation. We 
also performed Western Blot on embryonic muscle lysates to confirm the 
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immunofluorescence data (Fig. 2G): results show a strong decrease of MyHC-I 
protein in both Sox6 null and Tg:Mlc1f-Nfix2 samples, without major changes in total 
MyHC content. Interestingly, in Sox6 null muscles we found a drastic up-regulation 
of Eno3, a marker of fetal myogenesis (Messina et al. 2010), suggesting that Sox6 
may negatively regulate Eno3 expression. These results have been also confirmed by 
qRT-PCR on wt and Sox6 null embryonic muscle tissue showing significant MyHC-I 
decrease and Eno3 increase in absence of Sox6, while the levels of MyHC-emb 
mRNA do not change (Fig. 2H). It was previously reported that Sox6 directly 
regulates MyHC-I by binding to the 5’-upstream region in two different binding sites: 
the first is located at -375 base pairs (bp) from the transcription start site (TSS) in the 
proximal promoter and is critical for Sox6-dependent MyHC-I repression in fetal 
myotubes (Hagiwara et al. 2007); the second is located at -2900 bp from the TSS, in a 
distal muscle enhancer that is required for full promoter activity (Giger et al. 2000; 
Blow et al. 2010), but its function is unknown (An et al. 2011). In order to determine 
whether Sox6 acts directly on the MyHC-I regulative regions during embryonic 
myogenesis, we performed chromatin immunoprecipitation (ChIP) for Sox6 in 
differentiated embryonic myoblasts (Fig. 2I). Interestingly, we found that Sox6 binds 
to both MyHC-I regulative regions, suggesting that Sox6 directly activates MyHC-I 
expression during embryonic myogenesis. Moreover, Sox6 directly binds to the Eno3 
proximal promoter region in close proximity of the TSS and of a conserved consensus 
sequence for Nfix (Messina et al. 2010), thus suggesting a direct mechanism of 
repression mediated by Sox6 in embryonic muscle. Taken together, these data 
demonstrate that Sox6 acts as a positive regulator of the slow-twitch phenotype 
during the embryonic period, in sharp contrast with its function in fetal muscle (An et 
al. 2011; Quiat et al. 2011). Thus, Sox6 has opposite roles in fiber type specification 
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between embryonic and fetal myogenesis. On the contrary, Nfix is both sufficient and 
necessary to initiate the fetal-specific program. In fact, ectopic Nfix expression in 
embryonic muscle leads to transcriptional down-regulation of MyHC-I and up-
regulation of Eno3 (Fig. 2J), while Nfix deficiency in fetal muscle results in higher 
levels of MyHC-I and lower levels of Eno3 (Messina et al. 2010; and see below). 
 
Sox6 activity is impaired in fetal muscle in the absence of Nfix  
In order to study the possible cooperation of Sox6 and Nfix in fetal myogenesis, we 
performed immunofluorescence for Sox6 and total MyHC on frozen muscle sections 
from E16.5 wt and Nfix null mice (Campbell et al. 2008): results show that Sox6 is 
localized in the nuclei of about 60% of total fibers in both wt and Nfix null muscles 
(Supplemental Fig. S2A,B and yellow bars in Fig. 3E). We then performed 
immunofluorescence for Sox6 and MyHC-I on sections from the same mice. 
Interestingly, in contrast to wt muscle, where a large proportion of the nuclear Sox6 
positive fibers express low or null levels of MyHC-I, in the absence of Nfix we 
observed a marked increase in the number of nuclear Sox6 positive fibers that co-
express MyHC-I (Fig. 3A-D). Quantification of the immunofluorescence data reveals 
a two-fold increase in the percentage of nuclear Sox6/MyHC-I double positive fibers 
(from 12±3% to 28±7%; red bars in Fig. 3E). The Western Blot on isolated nuclear 
extracts from wt and Nfix null fetal muscle did not reveal significant differences in 
nuclear Sox6 protein content (Fig. 3F,G). We further validated these data by qRT-
PCR and Western Blot on differentiated fetal myotubes. Nfix null myotubes express 
higher levels of MyHC-I mRNA and protein compared to wt cells, but only a slight 
increase (non-significant) in Sox6 expression was detected (Supplemental Fig. 
S2C,D). These data demonstrate that, in the absence of Nfix, Sox6 repressive activity 
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on MyHC-I is partially impaired, even if the normal expression pattern of Sox6 is 
maintained. This suggests that cooperation between Nfix and Sox6 is required for 
normal fetal fiber type specification.  
 
Nfix is necessary for the binding of Sox6 to the MyHC-I proximal promoter  
On the basis of the results obtained and since Sox6 and Nfix are co-expressed starting 
from fetal myogenesis, we wondered whether they can bind to each other in a multi-
protein complex. To this aim we used C2C12 myoblasts transiently transfected with 
both Nfix2-HA- and Sox6-expressing plasmids (see Experimental Procedures), and 
we performed co-immunoprecipitation (Co-IP) assay for HA and Sox6. The Co-IP 
revealed a binding between Sox6 and Nfix-HA, as shown in Fig. 4A. Since Nfix 
presents both a trans-repression and a trans-activation domain, but it is unable to 
directly bind to the MyHC-I promoter (Messina et al. 2010), we hypothesized that 
physical association with Sox6 might provide the basis for transcriptional repression 
at the MyHC-I locus. In order to unravel a possible mechanism of cooperation, we 
performed ChIP for Sox6 in wt and Nfix null fetal myotubes (Fig. 4B). Results show a 
decrease in the normal binding of Sox6 to the two different sites in the MyHC-I 5’-
upstream region. Importantly, the binding with the proximal promoter was completely 
lost in the absence of Nfix, while the binding with the distal enhancer was reduced by 
50%. These data demonstrate that Nfix is required for the proper binding of Sox6 to 
the MyHC-I proximal promoter, and thus for the repressive activity of Sox6. Since we 
demonstrated that Sox6 directly represses Eno3 in embryonic muscle, we sought to 
determine whether Nfix might regulate the binding between Sox6 and the Eno3 
promoter as well. Importantly, Sox6 does not bind to the Eno3 promoter in fetal wt 
myotubes (An et al. 2011). However, in Nfix null myotubes we found the presence of 
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a binding, implying that Sox6 is incorrectly bound to Eno3 promoter in absence of 
Nfix. This further suggests that Nfix is required for the global function of Sox6 in 
fetal muscle. 
 
Sox6 is required for normal Nfix function in fetal muscle 
In the light of the observed cooperation between Nfix and Sox6, we also investigated 
Nfix function in Sox6 null fetuses (E17.5). As previously described in other mouse 
models (Hagiwara et al. 2007; An et al. 2011), fetal fiber specification is completely 
disrupted in the absence of Sox6. Indeed, in contrast to wt muscle, in Sox6 null 
fetuses the totality of muscle fibers present high levels of MyHC-I by 
immunofluorescence (Fig. 5A-B). We also performed immunofluorescence for Nfix 
on the same sections (Fig. 5C-F) and found that, despite the dramatic increase in 
MyHC-I expression, Nfix is correctly expressed in the nuclei of muscle fibers in 
absence of Sox6. Additionally, we performed qRT-PCR on wt and Sox6 null fetal 
myotubes. We found a slight but significant decrease of Nfix mRNA in the absence of 
Sox6 (Fig. 5G), suggesting that Sox6 may positively regulate Nfix expression. 
Importantly, MyHC-I mRNA levels are drastically increased (up to 6-fold) in the 
absence of Sox6. However, by performing Western Blot (Fig. 5H), we found no 
differences in Nfix protein content. These data demonstrate that Nfix is normally 
expressed in the absence of Sox6, but unable to properly repress MyHC-I. Since we 
demonstrated a critical requirement for Nfix in Sox6 muscle-specific activity, we 
sought to investigate whether Sox6 deficiency might lead to impairments in Nfix 
function as well. Therefore, we performed qRT-PCR on E12.5 and E16.5 wt and Sox6 
null muscle tissue. We observed that Nfix is normally up-regulated during fetal 
myogenesis in absence of Sox6, even if its levels in the E16.5 Sox6 null sample are 
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slightly decreased (consistently with the in vitro mRNA analysis; Fig. 6A). As 
expected, Sox6 null embryonic and fetal muscles display abnormal MyHC-I/MyHC-
emb ratios that reflect the down-regulation of MyHC-I during primary myogenesis 
and its subsequent up-regulation in the fetal period (Fig. 6B). Intriguingly, the MyHC-
neo/MyHC-emb ratio is not affected (Fig. 6C). Moreover, NFATc4 is markedly up-
regulated in Sox6 null embryonic muscle, but is normally repressed in the fetal period 
in absence of Sox6 (Fig. 6D), whereas Eno3 mRNA is barely expressed in Sox6 null 
fetuses (Fig. 6E), suggesting that Nfix was able to correctly regulate NFATc4 but not 
MyHC-I and Eno3 in absence of Sox6. Taken together, these date indicate that Sox6 
is required for the proper transcriptional function of Nfix during fetal development, 
thus demonstrating a non-redundant and cooperative function for Sox6 and Nfix in 
the achievement of fetal muscle phenotype (see the model in Fig. 6F). 
 
Functional cooperation of Sox6 and Nfixa is evolutionary conserved in zebrafish 
It is known that both Sox6 and Nfixa have an evolutionary conserved role in the 
repression of slow-twitch genes in zebrafish (von Hofsten et al. 2008; Pistocchi et al. 
2013). We thus wondered whether functional cooperation between Nfixa and Sox6 is 
conserved in zebrafish myogenesis. As a preliminary analysis, we performed 
immunofluorescence for Sox6 and total MyHC (MF20 antibody) or sMyHC1 (F59 
antibody) on 48 hours post-fertilization (hpf) embryos: we found that Sox6 is 
expressed in the majority of muscle fiber nuclei (Fig. 7A,B). Intriguingly, we found 
that the outer superficial fibers positive for sMyHC1 present cytoplasmic staining for 
Sox6 (Fig. 7C-J), suggesting that Sox6 subcellular localization may be differentially 
regulated in slow and fast muscle domains during zebrafish development. 
Additionally we performed qRT-PCR on tails isolated from zebrafish embryos at 24, 
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48 and 72 hpf: sox6 transcript is expressed at high levels at 24 hpf and is steadily 
down-regulated at 72 hpf (Supplemental Fig. S3A), whereas nfixa transcript peaks at 
48 hpf (Supplemental Fig. S3B) as previously shown (Pistocchi et al. 2013). In order 
to elucidate the role of Sox6 in slow-twitch genes regulation, we performed 
morpholino (MO) mediated knockdown of sox6 (von Hofsten et al. 2008). sox6 
morphants display a complex phenotype characterized by cardiac edema, vascular 
defects and abnormal motility that is not observed in control std-MO injected 
embryos (data not shown). By qRT-PCR analysis (Supplemental Fig. S3C-H) we 
found that the expression of slow-twitch specific genes such as smyhc1 and prox1a is 
markedly increased in absence of Sox6, whereas fast-twitch genes such as mylpfa 
(fast myosin light chain isoform) and tnnc2 (fast troponin C isoform) are expressed at 
equal or lower levels. Moreover, the nfixa transcript is drastically up-regulated since 
24 hpf in sox6 morphants, suggesting that Sox6 might negatively regulate nfixa, 
whereas nfatc4 is prematurely down-regulated, likely reflecting high Nfixa levels. We 
conclude that Sox6 is a critical repressor of the slow-twitch phenotype in zebrafish, 
and that Nfixa is not able to compensate for sox6 knockdown. To verify a possible 
cooperation between Nfixa and Sox6, we performed co-injections of suboptimal doses 
of sox6-MO and nfixa-MO (see Supplemental Experimental Procedures). Strikingly, 
qRT-PCR results show that smyhc1 and prox1a are significantly up-regulated in the 
double morphants, whereas mylpfa levels do not change (Fig. 7K). Moreover our 
analysis reveals that sox6 and nfixa transcripts are up-regulated in nfixa and sox6 
morphants respectively, suggesting a mechanism of compensation that is lost when 
both factors are targeted for knockdown. Therefore, we conclude that functional 
cooperation of Sox6 and Nfix is evolutionary conserved in mouse and zebrafish.  
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DISCUSSION 
 
In recent years, many works have demonstrated that the intrinsic transcriptional 
properties of embryonic and fetal muscle progenitors are important to set the fiber 
type in the absence of nerve activity. Moreover, several transcription factors 
contributing to whole muscle fiber type specification have been identified, including 
Sox6 (Hagiwara et al. 2007; An et al. 2011), Nfix (Messina et al. 2010), Six1/Six4 
(Richard et al. 2011) and the NFAT factors (Daou et al. 2013). However, the network 
of transcription factors controlling fiber type specification during embryogenesis is 
still far from being fully characterized, and functional interactions among the different 
regulators are until now completely unknown. In this work we provided evidence for 
functional cooperation of Nfix and Sox6 in the repression of the slow-twitch 
phenotype during fetal muscle development. In contrast to Nfix, which is a specific 
marker of fetal myogenesis (Messina et al. 2010; Mourikis et al. 2012), Sox6 is 
expressed in both embryonic and fetal purified myoblasts at the mRNA and at the 
protein level. Consistently we found that Sox6 protein is expressed at high levels in 
skeletal muscle in vivo starting from E12.5. This was unexpected, since Sox6 is 
known to be a repressor of MyHC-I, which along with MyHC-emb is expressed in all 
embryonic fibers (Hagiwara et al. 2007; Hutcheson et al. 2009). It is known that the 
Sox6 transcript is absent in mouse embryonic myotome from E9.5 to E10.75 (Vincent 
et al. 2012), suggesting that Sox6 might be quickly activated in embryonic myoblasts 
at the beginning of primary myogenesis. However, we found that Sox6 protein is 
differentially localized in embryonic and fetal muscle and during the embryonic 
period is mainly found in the cytoplasm of myocytes and myogenic cells. It is known 
that Sox factors are regulated by subcellular localization in different tissues 
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(Argentaro et al. 2003; Avilion et al. 2003). Sox6 is aberrantly accumulated in the 
cytoplasm of fetal fibers lacking both Six1 and Six4, thus leading to an up-regulation 
of slow-twitch genes (including MyHC-I) and a consequential decrease in fast-twitch 
genes expression (Richard et al. 2012). Moreover, Sox6 protein was found in the 
cytoplasm of muscle fibers in post-natal and adult mouse (An et al. 2011), suggesting 
that an unknown mechanism controlling Sox6 subcellular localization might be 
important in regulating Sox6 function in fiber type specification. The recent finding 
that Sox6 is targeted for proteasomal degradation by the E3 ubiquitin ligase Trip12 in 
C2C12 myoblasts (An et al. 2013), strongly suggests that Sox6 function may be 
specifically controlled at post-translational level. However, Sox6 protein was also 
found in the nuclei of embryonic myocytes, suggesting that Sox6 may be active as a 
transcription factor during primary myogenesis. Consistently, we found two 
downstream targets of Sox6 in embryonic muscle, MyHC-I and Eno3, which are 
regulated in opposite ways. To our knowledge, this is the first report of a possible 
function for Sox6 in the transcriptional regulation of embryonic muscle. 
Unexpectedly, Sox6 deficiency during primary myogenesis leads to a faster muscle 
phenotype with low levels of MyHC-I and high levels of Eno3. This is followed in 
Sox6 null fetuses by dramatic up-regulation of MyHC-I and loss of Eno3 expression. 
These data are consistent with previous characterizations of the Sox6 null phenotype 
(Hagiwara et al. 2007; An et al. 2011; Quiat et al. 2011) and demonstrate that Sox6 
plays opposite roles in fiber type specification during development. It was shown by 
ChIP and ChIP-seq analyses that the MyHC-I regulative regions contain at least two 
conserved binding sites for Sox6 (promoter and enhancer), while no Sox6 binding 
sites were found in the Eno3 promoter (An et al. 2011). We found that Sox6 binds to 
both MyHC-I binding sites in embryonic and fetal myogenic cells but with different 
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affinity (higher in fetal myotubes). Moreover, Sox6 binds to the Eno3 promoter in 
embryonic but not in fetal myoblasts. Thus, the binding ability of Sox6 is 
differentially regulated in discrete myogenic progenitor populations or at different 
times during development, which contributes to the high versatility of Sox6 functions. 
In contrast, we have shown that Nfix acts as a repressor of the slow-twitch phenotype 
in both embryonic and fetal muscle. 
It is known that SoxD factors, lacking trans-acting functional domains, have a critical 
requirement for co-factors in order to regulate transcription of target genes (Murakami 
et al. 2001). Therefore, it is likely that the reversal in Sox6 function is due to different 
factors that are progressively recruited and activated during muscle development. 
Preferential partners of Sox6 during embryonic myogenesis are likely positive 
transcriptional regulators, such as the MRFs (MyoD and Myog in particular), which 
bind to the same regulative regions of Sox6 in muscle cells (An et al. 2011). Then, 
starting from E16.5, we found that Nfix acts as a fundamental co-factor of Sox6, able 
to physically associate with Sox6 and to facilitate its binding with the MyHC-I 
regulative regions, in particular the proximal promoter that was shown to be critical 
for Sox6-dependent fetal repression (Hagiwara et al. 2007). Strikingly, our ChIP 
analysis reveals that in absence of Nfix the binding status of Sox6 in fetal myotubes 
resembles that of embryonic differentiated myoblasts, in particular for Eno3. 
Moreover, our study on Nfix null and Sox6 null fetuses clearly demonstrates that Sox6 
and Nfix are independently expressed during secondary myogenesis and that neither 
Sox6 nor Nfix are able to restore wt MyHC-I expression when the other one is not 
present. Finally, we demonstrated that Sox6 is required for at least two of the Nfix 
transcriptional functions in fetal muscle: repression of MyHC-I and activation of 
Eno3. The transcriptional regulation of MyHC-neo was not affected, suggesting that 
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Sox6 is dispensable for the MyoD/NFATc2-induced activation of MyHC-neo (Daou 
et al. 2013). 
In this work we have also provided evidence for a conserved transcriptional 
cooperation of Sox6 and Nfixa in zebrafish. Sox6 is expressed both at mRNA and 
protein levels in fast muscle fibers that are negative for sMyHC1, and it is here co-
expressed with Nfixa that is required for sMyHC1 down-regulation after 72 hpf 
(Pistocchi et al. 2013). We show that, as in mouse, Sox6 is crucial for repression of 
slow-twitch genes, even in presence of elevated Nfixa levels. Moreover, our double 
MO assay clearly reveals that the two factors can cooperate in repressing the slow 
muscle phenotype, whereas expression of fast-twitch genes such as mylpfa (Liew et 
al. 2008) was unaffected. 
In conclusion we have presented a complex model of regulation of the 
embryonic/fetal transcriptional switch that not only involves Nfix activation, driven 
by Pax7 and other unknown factors (Messina et al. 2010), but also functional 
cooperation between Nfix and Sox6 that is conserved in mammals and teleosts. Future 
work will be addressed to study the relationship between Sox6 and Nfix in the context 
of post-natal development and adult skeletal muscle growth. 
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EXPERIMENTAL PROCEDURES 
 
Mouse and fish strains and injection of embryos 
The following murine lines were used: Myf5GFP-P/+ (Kassar-Duchossoy et al. 2004); 
Nfix null (Campbell et al. 2008); Sox6lacZ/+ (Smits et al. 2001); Tg:Mlc1f-Nfix2 
(Messina et al. 2010). For each of these lines the genotyping strategy has been 
described in the references. CD1 wt mice (Jackson Lab) were used as well. All animal 
studies were housed at the Departmental animal house. Mice were kept in pathogen-
free conditions and all procedures were conformed to Italian law and approved by the 
University of Milan and Use Committee.  
Zebrafish were raised and maintained according to established techniques. The 
following strains were used: AB (from the Wilson lab, UCL, London, UK). 
 
Immunofluorescence on sections 
Mouse or zebrafish embryos were fixed in 4% paraformaldehyde, extensively washed 
in PBS and incubated overnight in PBS containing 15% sucrose. Samples were then 
frozen in isopentane/liquid nitrogen. Cryostat sections (8 µm thickness) were 
permeabilized in 1% bovine serum albumin, 0,2% Triton-X 100 in PBS for 30 min at 
RT, incubated 1 h in blocking solution (10% goat serum in PBS) and overnight with 
the primary antibody or with mock PBS. After incubation for 30 min with the 
fluorescent-conjugated secondary antibody (Jackson ImmunoResearch), sections were 
again washed in PBS 0,2% Triton-X 100, mounted and examined under 
epifluorescence microscope (Leica). The following primary antibodies were used: 
rabbit anti-Sox6 (Abcam ab30455, 1:300), rabbit anti-Nfix (Novus Biological, 1:200), 
mouse anti-MyHC-I (Sigma, 1:200), MF20 (monoclonal, 1:2), F59 (monoclonal, 
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1:10), anti-Myog (monoclonal, 1:2), mouse anti-MyoD (BD Biosciences, 1:200 ). 
Nuclei were stained with Hoechst (1:1000). 
 
Cell sorting and culturing 
Dissected Myf5GFP-P/+ embryos or fetuses were digested by 0,1% collagenase D 
(Roche) and 0,25% Trypsin (Gibco) for 20 min at 37°C in agitation as described in 
Biressi et al. 2007. After centrifugation and filtration, the cells were collected in 
DMEM, 20% FBS, 2 mM EDTA, 20 mM HEPES. Cell sorting was performed in 
MoFlo System (DAKO). GFP+ cells were collected for mRNA and protein 
extraction. For the preparation of unpurified myoblasts, after digestion of the tissue 
we performed a pre-plating of 30 min to separate fibroblasts. Unpurified cells were 
kept for 12 h in a low oxygen (3%) incubator at 37°C in DF20 (20% FBS in DMEM). 
Then the plates were checked for fibroblasts contamination and allowed to 
differentiate in DM (2% horse serum in DMEM) for 48 h. 
 
Protein extraction and Western Blot 
Cultured cells were washed twice in ice-cold PBS and then lysed (30 min in ice) with 
RIPA buffer (10 mM Tris-HCl pH 8.0, 1mM EDTA, 1% Triton-X, 0,1% sodium 
deoxycholate, 0,1% SDS, 150 mM NaCl in deionized water) plus protease inhibitors 
(1 mM PMSF). Proteins were harvested after centrifugation, quantified by absorbance 
reading at 750 nm and stored at -80°C. Proteins were then separated on 8%-12% 
polyacrylamide gels or on MiniProtean TDX Gels (Biorad) migrated for 2-3 h at 100 
V (constant voltage). For Western Blot analysis the proteins were transferred onto 
nitrocellulose with the iBlot Dry Blotting System (Invitrogen). Following transfer, the 
membranes were blocked in 5% milk in phosphate buffer to eliminate non-specific 
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binding. The primary antibodies used are: rabbit anti-Sox6 (Abcam ab30455), mouse 
anti-slow MyHC (Sigma), mouse anti-tubulin (Santa Cruz), rabbit anti-Nfix (Novus 
Biological), goat anti-Lamin B (Santa Cruz), mouse anti-HA (Covance), mouse anti-
vinculin (Sigma), mouse anti-β-enolase (BD Biosciences). HRP-conjugated 
antibodies (Biorad) were used as secondary antibodies, and the signal was revealed 
with the ChemiDoc MP System (Biorad). For the nucleus/cytoplasm fractionation 
protocol, see Supplemental Experimental Procedures. 
 
Transfection and co-immunoprecipitation assays 
C2C12 myoblasts were plated on 90 mm dishes and allowed to reach 90% confluence 
in proliferating conditions. Cells were co-transfected with pCHX-Nfix2-HA and ZS-
Green IRES Sox6 plasmids with Lipofectamine LTX (Invitrogen) over night at 37°C. 
Cells were kept in DM for 24 h, then proteins were extracted in IP Lysis Buffer, 
containing 50 mM Tris-HCl pH 8.0, 1% NP40, 0,5% sodium dehoxycholate, 150 mM 
NaCl, protease and phosphatase inhibitors. Immunobinding was performed over night 
at 4°C with 5 µg of rabbit anti-Sox6 antibody (Abcam), rabbit anti-HA antibody 
(Santa Cruz) or non-related rabbit IgG (Santa Cruz) and 1 mg of total proteins per 
condition. Sepharose-conjugated Protein A (GE Healthcare) was used for 
immunoprecipitation of the antibody-antigen complex. 
 
Chromatin immunoprecipitation (ChIP) 
The ChIP for Sox6 was performed as published (An et al. 2011). For the detailed 
protocol see the Supplemental Experimental Procedures. 
 
RNA extraction and analysis  
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RNA from homogenized embryos or from pelleted cells was extracted with 
NucleoSpin RNA kits (Macherey-Nagel) following manufactures instructions. Eluted 
RNA was checked on 1.6% agarose gels, quantified with a Nanodrop 
spectrophotomer and stored at -80°C. Approximately 1 µg of RNA was used with the 
ImProm-II Reverse Transcriptase kit (Promega). Real Time PCR was performed on 
cDNA using SYBR Green Supermix (Biorad) and the CFX Connect Real Time 
System (Biorad). After amplification, relative mRNA expression levels were 
calculated using standard curves from cDNA dilutions, and normalized on the Gapdh 
expression levels. For qRT-PCR in zebrafish we used two different normalizers: ef1a 
and rpl8. The primers used are listed in Supplemental Tables S1 and S2.  
	  
MO microinjections  
Antisense morpholinos (MOs; Gene Tools, Philomath, OR) used in this study were 
already described: sox6-MO1 (von Hofsten et al. 2008), nfixa-MO (Pistocchi et al. 
2013). MOs, diluted in Danieau buffer (Nasevicius and Ekker, 2000), were injected at 
1- to 2-cell stage. Escalating doses of each MO were tested for phenotypic effects; as 
control for unspecific effects, each experiment was performed in parallel with a std-
MO (standard control oligo) with no target in zebrafish embryos. We usually injected 
0.8-1.0 pmol/embryo of nfixa-MO, 0.5 pmol/embryo of sox6-MO1. For combined 
knockdown experiments, we injected sox6-MO1 and nfixa-MO at 0.1 and 0.25 
pmol/embryo respectively. 
 
Statistical analysis 
Values were expressed as means ± SD. Statistical significance was assessed by 
unpaired Student’s t test with Prism 5 software. Statistical significance with a 
probability of less than 5%, 1% or 0,5% was indicated in each graph with *, **, *** 
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respectively, followed by the number (N) of independent experiments. 
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FIGURE LEGENDS 
 
Figure 1. Sox6 is equally expressed but differentially localized during primary 
and secondary myogenesis. A) qRT-PCR analysis on Myf5GFP-P/+ embryonic (E12.5) 
and fetal (E16.5) myoblasts showing unaltered expression of Sox6 transcript in the 
two populations. B) Western Blot on lysates from freshly isolated Myf5GFP-P/+ 
embryonic and fetal myoblasts. β-tubulin was used to normalized the amount of 
protein loaded. C-F) Immunofluorescence with antibodies anti-Sox6 (green) and 
MF20 (recognizing all MyHC isoforms, red) on frozen sections of embryonic (E12.5) 
skeletal muscle. Arrowheads show co-localization of Sox6 and MyHC in the 
cytoplasm of myogenic cells. Nuclei are counterstained with Hoechst. Scale bars: 25 
µm. G-J) Immunofluorescence with antibodies anti-Sox6 (green) and MF20 (red) on 
frozen sections of fetal (E16.5) skeletal muscle, showing nuclear localization of Sox6 
in the developing fibers (arrows). Nuclei are counterstained with Hoechst. Scale bars: 
25 µm. K) Quantification of the immunofluorescence data (the percentage of nuclear 
or cytoplasmic Sox6 events was calculated on the total number of Sox6/MyHC 
double positive cells; N=3). L) Western blot with nuclear (N) and cytoplasmic (C) 
fractions extracted from E12.5 and E16.5 muscle tissue. β-tubulin and Lamin B are 
shown for normalization of the cytoplasmic and nuclear extracts, respectively. The 
arrow marks the 90 kDa Sox6 band; the asterisk marks the modified band for Sox6. 
 
Figure 2. Sox6 acts as a positive regulator of MyHC-I during embryonic 
myogenesis. A-F) Immunofluorescence on E12.5 muscle sections from wt (A,D), 
Sox6 null (B,E) and Tg:Mlc1f-Nfix2 (C,F) mice stained with antibodies anti-MyHC-I 
(A-C) or MF20 (C-F). Scale bars: 100 µm. G) Western blot on E12.5 muscle samples 
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from wt, Sox6 null and Tg:Mlc1f-Nfix2 mice. Vinculin was used to normalize the 
amount of loaded protein. H) qRT-PCR on E12.5 muscle tissue from wt and Sox6 null 
mice (*p<0,05; **p<0,01; ***p<0,005; N=3). I) ChIP assay with anti-Sox6 on E12.5 
differentiated myoblasts. Four different chromatin regions were tested: a negative 
control region (intergenic), the MyHC-I proximal promoter (-375 bp; MyHC-I 
promoter), the MyHC-I distal enhancer (-2900 bp; MyHC-I enhancer) and the Eno3 
proximal promoter (*p<0,05; N=2). J) qRT-PCR on E12.5 muscle tissue from wt and 
Tg:Mlc1f-Nfix2 embryos (*p<0,05; **p<0,01; ***p<0,005; N=3). 
  
Figure 3. Nfix is necessary for the correct function of Sox6 in fetal muscle. A-D) 
Immunofluorescence with anti-Sox6 (green) and anti-MyHC-I (red) antibodies on 
fetal (E16.5) muscle sections from wt (A,B) and Nfix null (C,D) mice. Arrows 
indicate secondary fibers which present nuclear Sox6 expression and low or absent 
staining for MyHC-I. Arrowheads indicate fibers co-expressing nuclear Sox6 and 
MyHC-I. Nuclei are counterstained with Hoechst. Scale bars: 25 µm. E) 
Quantification of the immunofluorescence data showing the percentage of nuclear 
Sox6 positive/MyHC positive fibers (yellow bars) and the percentage of nuclear Sox6 
positive/MyHC-I positive fibers in wt and Nfix null fetal muscle (red bars; 
***p<0,005; N=3). F) Western Blot for Sox6 on nuclear (N) protein extracts from wt 
and Nfix null fetal muscle. Lamin B was used to normalize the amount of proteins 
loaded. Black squares mark lanes run on a separate gel but using the same samples 
and amounts of input protein. G) Quantification of the pixel intensity for Sox6 on two 
independent Western Blot experiments, one of which is depicted in Fig. 3F. 
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Figure 4. Nfix is required for the correct binding of Sox6 to the MyHC-I 
promoter. A) Immunoprecipitation assay on C2C12 myoblasts transfected with 
Nfix2-HA- and Sox6 vectors, showing co-immunoprecipitation of HA and Sox6 (T= 
total lysate; IgG= negative control). B) ChIP assay with anti-Sox6 on wt and Nfix null 
E17.5 myotubes on the same chromatin regions descripted in Fig. 2I  (*p<0,05; 
**p<0,01; N=2). 
 
Figure 5. Sox6 is critical for MyHC-I transcriptional repression in fetal muscle. 
A,B) Immunofluorescence with anti-MyHC-I antibody on E17.5 muscle sections from 
wt (A) and Sox6 null (B) mice. Scale bar: 50 µm. C-F) Immunofluorescence with 
antibodies anti-Nfix (green) and anti-MyHC-I (red) on E17.5 muscle sections from wt 
(C,D) or Sox6 null (E,F) mice. Arrows indicate Nfix positive nuclei in secondary 
(MyHC-I negative) fibers. Arrowheads indicate Nfix positive nuclei in MyHC-I 
positive fibers. Nuclei are counterstained with Hoechst. Scale bars: 25 µm. E) qRT-
PCR on wt and Sox6 null E17.5 myotubes (*p<0,05; **p<0,01; ***p<0,005; N=3). F) 
Western Blot on wt and Sox6 null E17.5 myotubes. β-tubulin was used to normalize 
the amount of proteins loaded. 
 
Figure 6. Sox6 is required for normal Nfix function in fetal muscle. A-E) qRT-
PCR analysis on E12.5 and E16.5 wt (white bars) and Sox6 null (black bars) muscle 
tissue. In the case of MyHC-I/MyHC-emb ratio (B) and of MyHC-neo/MyHC-emb 
ratio (C) the normalized values of MyHC-I and MyHC-neo (on Gapdh) were divided 
for the normalized value of MyHC-emb (on Gapdh) (*p<0,05; **p<0,01; ***p<0,005; 
N=2). F) Model proposed for cooperation between Sox6 and Nfix during primary 
(E12.5) and secondary (E16.5) myogenesis. 
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Figure 7. Functional cooperation of sox6 and Nfixa is conserved in zebrafish. A-
J) Immunofluorescence with anti-Sox6 antibody (green) and MF20 (red) (A-B,G-J) 
or with anti-Sox6 (green) and anti-sMyHC1 (F59, red) (C-F) on 48 hpf zebrafish 
muscle longitudinal sections. Arrowheads indicate Sox6 positive nuclei in fast-twitch 
muscle fibers. Arrows indicate Sox6 staining in the cytoplasm of superficial slow 
fibers. Nuclei are counterstained with Hoechst. Scale bars: 25 µm. K) qRT-PCR 
analysis on tails from std-MO, sox6-MO, nfixa-MO and sox6-MO:nfixa-MO 48 hpf 
embryos (*p<0,05; **p<0,01; ***p<0,005; N=2). 	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SUPPLEMENTAL INFORMATION 
 
SUPPLEMENTAL DATA 
 
Supplemental Figure S1. Sox6 is expressed in both embryonic and fetal muscle 
cells. A-H) Immunofluorescence with antibodies anti-Sox6 (green) and anti-MyoD 
(red) (A-D) or anti-myogenin (red) (E-H) on E12.5 muscle sections showing 
cytoplasmic localization of Sox6 in myoblasts and myocytes (arrows in the panels). I-
L) Immunofluorescence with antibodies anti-Sox6 (green) and anti-MyHC-I (red) on 
E17.5 muscle sections, showing nuclear expression of Sox6 in MyHC-I negative 
(secondary) fibers (arrows). Nuclei are counterstained with Hoechst. Scale bars: 25 
µm. 
 
Supplemental Figure S2. Sox6 is normally expressed in fetal muscle in the 
absence of Nfix. A,B) Immunofluorescence with anti-Sox6 antibody (green) and 
MF20  (red) on fetal (E16.5) muscle sections from wt and Nfix null mice. Scale bars: 
25 µm. C) qRT-PCR on wt and Nfix null E17.5 myotubes (** p<0,01; N=3). The 
increase in Sox6 mRNA expression is not statistically significant. D) Western blot on 
lysates from wt and Nfix null E17.5 myotubes showing increased MyHC-I expression 
and equal Sox6 expression in the absence of Nfix. β-tubulin was used to normalize 
the amount of proteins loaded. 
 
Supplemental Figure S3. Knock-down of sox6 in zebrafish embryos impairs the 
Nfixa/Nfatc4 axis function. A,B) qRT-PCR for sox6 (A) and nfixa (B) on tails 
collected from 24, 48 and 72 hpf zebrafish embryos. C-H) qRT-PCR for nfixa, nfatc4, 
smyhc1, prox1a, mylpfa, tnnc2 on tails collected from std-MO and sox6-MO injected 
embryos at 24 and 48 hpf (*p<0,05; **p<0,01; ***p<0,005; N=2). 
 
  
Supplemental Table S1. Primers used for mRNA expression analysis with 
quantitative Real Time PCR (Mus musculus) 
 
Gene Primers sequence Notes 
Sox6 F:AATGCACAACAAACCTCACTCT 
R:AGGTAGACGTATTTCGGAAGGA  
 
MyHC-I (Myh7) F:AGGGCGACCTCAACGAGAT 
R:CAGCAGACTCTGGAGGCTCTT  
Mathew et al. 
2011 
MyHC-emb (Myh3) F:GCAAAGACCCGTGACTTCACCTCTAG 
R:GCATGTGGAAAAGTGATACGTGG 
Mathew et al. 
2011 
MyHC-neo (Myh8) F: GTCACGCAATGCAGAAGAGA 
R: CAGGTCCTTCACCGTCTGTT 
Mathew et al. 
2011 
Nfix F:CACTGGGGCGACTTGTAGAG 
R:AGGCTGACAAGGTGTGGC 
Mourikis et al. 
2012 
NFATc4 F:TACAGCAACAAGCGGGTGTC 
R:CGGAGAGATGAGTCTGGTAGGG 
 
Myog F:GACATCCCCCTATTTCTACCA 
R:GTCCCCAGTCCCTTTTCTTC 
 
Eno3 F:CAGCTTGTTTCCAGCATGAG 
R:CTCTACCGACACATCGCAGA 
Mourikis et al. 
2012 
Gapdh F:GGCATGGACTGTGGTCATGA 
R:TTCACCACCATGGAGAAGGC 
 
 
  
Supplemental Table S2. Primers used for mRNA expression analysis with 
quantitative Real Time PCR (Danio rerio) 
 
Gene Primers sequence Notes 
nfixa F:ACCGAAGAAACCGACTGGTG 
 
 
R:TCTGTGGCCATTGTAGTTCAGG 
 
sox6 
F:GCGCATGGAATCGGACAG 
R:GGCTTGTGTGGAGAGGTAGAG  
 
smyhc1 
F:GCTAACAGGCAGGCATCAGA  
R:GTTGCATTTGGGAATCCTTGACA  
 
mylpfa F: GCGGCTTCAGACTTCTCTTCTTG 
R: CTTCTTGGGTGCCATGTCGAG 
 
tnnc2 F:CAATCATGACTGACGCGCAA 
R:GCCACCGTCAGTATCGAACA 
 
nfatc4 F:GCGCATAGAAGTACAGCCCA 
R:TAGCCCACAAGCTTCACCAC 
 
prox1a 
F: CCAACCACCTCAGTCACCAT 
R: CCCCTCTTGGATTGTACTTCCT 
 
ef1a 
F:CTGGAGGCCAGCTCAAACAT 
R:ATCAAGAAGAGTAGTACCGCTAGCATTAC 
 
rpl8 
F:GCAAACAGAGCCGTTGTTG 
R:CCTTCAGGATGGGTTTGTCA 
 
 
  
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Preparation of nuclear and cytoplasmic protein extracts 
Eviscerated embryos and fetuses were homogenized for 1 min in ice with 300-500 µl 
of STM buffer comprising 250 mM sucrose, 50 mM Tris–HCl pH 7.4, 5 mM MgCl2, 
protease and phosphatase inhibitor cocktails (Dimauro et al. 2012). After 
centrifugation, the supernatant was kept as cytoplasmic extract, while the pellet was 
washed twice in hypotonic buffer without detergents, resuspended in NE buffer 
(containing 20 mM HEPES pH 7.9, 1.5 mM MgCl2, 0.5 M NaCl, 0.2 mM EDTA, 
20% glycerol, 1% Triton-X-100, protease and phosphatase inhibitors) and centrifuged 
30 min at 43000 rpm at 4°C. The supernatant was kept as nuclear extract. 
Cytoplasmic and nuclear extracts were then quantified and loaded on polyacrylamide 
gels for Western Blot analysis.  
 
Chromatin immunoprecipitation (ChIP) 
ChIP was performed as previously published (An et al. 2011). Briefly, primary 
myoblasts were crosslinked for 10 min at RT in 1% formaldehyde (Sigma) in PBS, 
then the crosslinking was quenched with 0,25 M glycine in PBS (10 min) and the 
cells were pelleted and lysed in Sonication Buffer containing 10 mM TRIS-HCl pH 
8.0, 1 mM EDTA, 1% SDS in deionized water. Sonication was performed in a 
Bioruptor Diagenode with three pulses of 5 min at maximum intensity. Chromatin 
was de-crosslinked and checked for 200-500 bp DNA fragments enrichment. 
Immunoprecipitation was performed with 3-5 µg of the following antibodies: goat 
anti-Sox6 (Santa Cruz), normal goat IgG (Santa Cruz). After elution, de-crosslinking 
and DNA extraction and precipitation, the samples were analyzed by qRT-PCR. The 
following primers were used for amplification of the MyHC-I proximal promoter 
region (promoter): CCCCACCCCCTGGAACT (fw), 
CCAGCTAGGAAACAATTGGAAGTG (rev); for the MyHC-I distal promoter 
region (enhancer): ACACCGCCCACTCAATACAC (fw), 
GCCCTCTCCAAACACTCTTG (rev); for a negative control region located 15 Kb 
upstream of the MyHC-I gene (intergenic): TCGGACCGGAGTGTTAGGAA (fw), 
ACCCTGGAGTCTCAGCATCG (rev) (An et al. 2011); and for the proximal Eno3 
promoter: CCAGGTCAGGAGCTTTTGCT (fw), CCGCCTCTCTCATTCCATCC 
(rev). The fold enrichment of each sample was calculated as percentage of input for 
internal control and then normalized on the IgG value.	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